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The majority of all treated cases of traumatic brain injury are classified as being in the mild 
severity range (MTBI) but many symptoms are far from mild and can result in difficulties 
that persist for years after the initial injury, severely affecting quality of life.  Chronic 
depression and anxiety symptoms can be masked by acute post-concussion symptoms and 
can affect males and females differently in the long-term but little research has been 
undertaken in this area.  The aims of this study were to investigate the gender differences in 
depression and anxiety over 1-month, 12-months and 8-years following a mild traumatic 
brain injury and to investigate gender differences in depression and anxiety between a group 
of MTBI subjects (8-years post-injury), and a group of participants who were TBI-free, by 
comparing Hospital Anxiety and Depression Scale (HADS) scores and self-reported 
symptoms.  A MTBI cohort consisting of a population-based sample of 151 adults who 
sustained a mild TBI between 2010 and 2011 was identified from an earlier longitudinal 
study: Brain Injury Incidence and Outcomes New Zealand In the Community Study 
(BIONIC).  Additionally, 213 participants with no history of head injury were recruited for 
comparison.  Both groups answered questions about current anxiety and depression 
symptoms using the HADS. 
Overall, results suggest that males and females with MTBI have the same overall 
course of recovery in relation to depression and anxiety symptoms over the 8-years following 
injury but that females consistently report significantly increased symptoms than males over 
time, as reflected in the general population.  Depression and anxiety scores fluctuate over the 
8-years post-MTBI but, overall, depression increases, anxiety decreases and symptom levels 
are below clinical severity.  Females with MTBI are significantly more likely than males to 
experience anxiety in the clinical range at 12-months post-injury.   
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There were no significant gender differences in depression or anxiety levels between 
the MTBI and comparison groups, and average HADS scores were not significantly different 
between groups.  However,  individual symptom analysis showed that females who were 8-
years post-MTBI experienced increased panic symptoms than females with no TBI and that 
both males and females with MTBI reported increased anhedonia and “restlessness’ 
symptoms than those without MTBI.   Overall, females reported significantly higher severity 
symptoms related to nervousness and feeling slowed down than males. 
The clinical implications of this study suggest a focus on the longer-term impacts of 
MTBI  as patients may experience later onset depression or anxiety that may not be present in 
the acute phase.  Evaluating individual symptoms as well as overall scores on measures can 
identify important clinical effects at symptom level that are masked by total score analysis.     
Practitioners should consider gender differences in how patients respond to self-report 
symptom measures to ensure accurate clinical assessment of both males and females, 
particularly in relation to MTBI which has a higher male prevalence.  Future research into 
MTBI outcomes that includes a broader range of measures, in addition to self-report, will 
ensure comprehensive clinical data is obtained about individual symptoms and risk factors.  
This study uniquely contributes to current research into gender outcomes post-MTBI 
and may guide clinical practice to develop effective, timely and targeted assessment and 
treatment interventions for depression and anxiety symptoms experienced by both males and 
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Traumatic Brain Injury (TBI) is a leading cause of injury-related death and disability 
worldwide and is projected to become the third largest cause of disease burden by 2020 due 
to its lasting effects and high cost of treatment and rehabilitation (Cassidy et al., 2004).  Road 
traffic accidents, falls, personal assault and exposure to mechanical forces often lead to head 
injury causing trauma to the prefrontal and anterior temporal structures of the brain which can 
produce a spectrum of damage ranging from focal lesions to extensive axonal injury resulting 
in contusions and extracerebral haemorrhages.  This damage and cell loss, which may go 
undetected in mild trauma, may lead to long-term difficulties with physical, cognitive, 
behavioural, emotional and psychosocial functioning (Jorge et al., 2004).  This can make 
activities of daily living and community reintegration problematic for TBI patients and their 
caregivers and can significantly affect their quality of life in the longer-term (Fann, 1997).   
The social and economic impact of TBI can be significant with increased 
unemployment rates, work limitations and long-term productivity losses (Theadom et al., 
2018).  TBI incurs significant economic burden and in New Zealand in 2010 the lifetime cost 
of all TBI survivors was estimated to be US$146.5 million, and expected to rise to US$177 
million in 2020 (Te Ao et. al., 2014).  With the substantial effects on public health and 
significant economic burden, exploring outcomes of TBI in the population is an important 
part of finding and delivering the most effective prevention and intervention strategies post-
injury.  Longitudinal studies are useful in tracking outcomes over time and the current study 
was based upon an eight year follow up of novel findings from the original participants from 
the Brain Injury Incidence and Outcomes New Zealand in the Community (BIONIC) study,  
a large population-based study carried out between 2010-11 that examined the incidence and 
outcomes (up to 12-months) of TBI across all age groups (Feigin et. al., 2013).   
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Definition of TBI and Injury Severity 
The World Health Organisation (WHO) defines TBI as “an acute brain injury 
resulting from mechanical injury to the head from external physical forces” (Carroll, Cassidy, 
Holm, Kraus & Coronado, 2004, p. 115).  This may include one or more of the following 
effects: confusion or disorientation; loss of consciousness; post-traumatic amnesia; other 
neurological abnormalities, such as focal neurological signs, seizure and/or intracranial lesion 
(and not due to drugs, alcohol or medications, other injuries or treatment for other injuries 
(e.g. systemic injuries, facial injuries or intubation), or other problems (for example, 
psychological trauma, language barrier, co-existing medical conditions). TBI severity was 
classified in the current study using the widely-used Glasgow Coma Scale (GCS, Teasdale & 
Jennett, 1974) and based on suggested criteria for population-based studies of incidence in 
TBI by Barker-Collo & Feigin, (2008).  The GCS classifies TBI into one of three categories: 
mild, moderate or severe. This measures motor responses, eye opening and verbal 
performance following injury to assess the depth and duration of impaired consciousness and 
coma.  Mild TBI is defined as a GCS of 13-15 or post traumatic amnesia (PTA) within 24 
hours of injury; moderate TBI is defined as GCS 9-12 or PTA within 1-6 days of injury; and 
severe TBI is defined as GCS 8 or lower or a PTA of 7 or more days from injury.  
Epidemiology 
The global epidemiology of Traumatic Brain Injury (TBI) is not well documented in 
the current literature due to the challenges of nonstandardised and heterogenous reporting 
among epidemiological studies both nationally and internationally.  A meta-analysis, 
conducted of pooled studies in North America in 2016, reported an incidence of 331 per 
100,000 people and in Europe 228 per 100,000 but these figures were obtained from TBI 
diagnosed via hospital records and did not capture incidences of mild TBI that did not present 
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to hospital.  The BIONIC study incidence rate for TBI in New Zealand was found to be 790 
per 100 000 people per year (95% CI 749-832), (Feigin, et al., 2013).  This is high compared 
to a range of between 47 cases and 618 cases per 100,000 person-years within other high-
income countries in Europe and North America (Andelic, 2013). Andelic posits that the 
incidence of TBI in New Zealand, and particularly mild TBI, exceeds those estimated by 
previous studies undertaken due to variations in the diagnostic criteria and methods used 
between the different studies.  Feigin et al., (2013) utilised  the case ascertainment method at 
a population level and included individuals with mild TBI who were not admitted to hospital 
(people who are often overlooked in hospital-based TBI studies, Setnik & Bazarian, 2007), 
and this may be more representative of actual prevalence of TBI in New Zealand.  In fact, 
according to Feigin et al., (2013), 749 cases per 100,000 person-years are classified as MTBI 
(95% CI 709-790 for MTBI and 95% CI 31-51 for moderate to severe TBI).  For this study, 
the majority of cases were MTBI and  my research specifically focuses on outcomes in adults 
after MTBI. 
Mechanism of Injury 
In New Zealand, 38% of TBI cases were due to falls (516 of 1369), 21% were due to 
mechanical forces (288 of 1369) and 20% were due to transport accidents (277 of 1369).  
Falls caused 82% of TBI in adults older than 65 years and exposure to mechanical forces was 
to blame for 48% of TBI in adolescents and young adults (Feigin et al., 2013).   
Mild Traumatic Brain Injury (MTBI) 
The majority of all treated cases of TBI (95%) are classified as being in the mild 
severity range (Feigin et al., 2013).  The risk of sustaining a MTBI is more than 18 times 
greater than the risk of sustaining a moderate to severe TBI and nearly a third of people will 
experience a MTBI by the time they are 25 years of age (Feigin et al., 2013).  By virtue of 
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their mild presentation, the deleterious effects of MTBI’s are often undetected and are 
therefore left untreated rendering the full burden of MTBI unknown. Wood, 2004 described 
the undetected effects of MTBI as a “silent epidemic”  (p.1149) as MTBI is one of the most 
common neurological conditions experienced by people overall. MTBI, which includes  
‘concussion’ and defined as a GCS score of 13-15 and PTA within 24 hours of injury, has 
been recognised by the World Health Organisation (WHO) as a public-health concern 
(Cassidy et al., 2004) as it can lead to substantial disruptions in education and working life 
(Khan, Baguley & Cameron, 2003).  Although injury severity is the most reliable predictor of 
outcomes after moderate and severe TBI, the impact of mild TBI is not so clear cut and there 
is evidence that socio-demographic and contextual factors, as well as the nature of the MTBI 
injury, may also determine longer term outcomes (Theadom et al., 2018), even though it was 
previously thought that people made a good recovery from MTBI within the first few months 
post-injury (Ruff, 2005).  A significant proportion of those sustaining a MTBI continue to 
report problems far beyond the typical 1-3 month recovery period (Mcmahon, et al., 2014) 
and there is now accruing evidence that nearly half of those affected by even mild traumatic 
brain injury (MTBI) go on to experience on-going difficulties such as cognitive and 
emotional impairments that can significantly disturb daily functioning in the long-term 
(Theadom et al., 2016).   
Mild TBI affects boys and men at a greater rate than women and girls (RR 1.73, 95% 
CI 1.54-1.93, Feigin et al., 2013) and this may be due to lifestyle differences such as levels of 
risk-taking activities, exposure to work-related hazards and violent assault-related injuries.  In 
terms of gender differences of MTBI, despite males being more likely to sustain a MTBI, 
female gender was associated with poorer outcomes at 12-months post-injury (Theadom et 
al., 2016). 
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Regarding the physiological effects of MTBI, Busch and Alpern, 1998, suggested that 
the mechanism of injury is inertial forces as opposed to impact, which stretch and fracture 
axons, disrupt cell bodies, tear blood vessels and interrupt blood flow (diffuse axonal injury 
or DAI) which can be extensive, even in MTBI.  Whilst most MTBI patients do not have 
access to or opportunity for brain imaging measures to identify DAI, neuro-radiological and 
neuro-pathological investigations have found diffuse brain damage in the frontal and 
temporal lobe, corpus callosum and fornices in those with MTBI which are linked with 
information processing deficits.  DAI has also been associated with deficits in executive 
functioning due to the profusion of white matter (Barker-Collo, 2015).  Advances in 
neuroimaging during the past 15 years have required researchers, clinicians, and policy 
makers to revise their views about MTBI as a fully reversible injury that can be repeated 
without consequences as more recent studies suggest that the life-long effects of MTBI, 
especially when repetitive, may be more severe than initially believed.  This is due to a 
marked increase in the diagnoses of chronic traumatic encephalopathy (CTE) amongst 
recently deceased athletes (McKee et al., 2013) and in neuroimaging studies of MTBI which 
have found that neuronal pathology may be present long after post-concussion assessment 
outcomes have returned to pre-morbid levels of functioning (Bigler, 2013).  As a result of this 
new research, it has been suggested that a single concussion can result in lifetime impairment 
for some individuals.  
MTBI is estimated to cost 40% of the total annual cost of TBI in the USA ($60 billion 
U.S. Dollars) (Finkelstein, Corso & Miller, 2006).  As well as the financial cost of treatment, 
many people experience a reduced quality of life due to the effects of MTBI.   Although, for 
many people, functional recovery usually improves over 3 months, patients with MTBI 
frequently take one month or longer to return to work, and unemployment at 3 months could 
be as high as a third of patients (Bloom et al., 2018).  When returning to work, patients with 
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MTBI have reported that they expend greater effort and become more fatigued relative to pre-
injury suggesting persistent post-injury effects of MTBI. 
The burden of MTBI is not just experienced by the patient and the challenge for 
families of those who have sustained a MTBI is recognising, acknowledging and 
understanding the persistence of their loved-ones often ‘invisible’ symptoms (Saban, Hogan, 
Hogan, & Pape, 2015). 
Symptoms and outcomes of MTBI. 
The range of post-MTBI complaints, collectively known as post-concussive 
symptoms (PCS), can include physical symptoms, such as headache, visual disturbances, 
sensitivity to noise, dizziness and fatigue, affective disturbances, such as emotional lability, 
irritability, anxiety and depression, and cognitive problems, such as difficulty concentrating, 
mental slowness, difficulty in dividing attention, and memory deficits (Ponsford et al., 2012; 
Emanuelson et al., 2003; Theadom et al., 2016).    
Of the persistent complaints reported, cognitive difficulties are most common and the 
most substantial contributors to long-term disability after MTBI (Clarke, Genat & Anderson, 
2012).  Emotional processing following MTBI has not been as widely examined as cognitive 
difficulties but depressive and anxiety symptoms with similar characteristics might be 
observed as part of the PCS in both the short and long-term and, indeed, cognitive complaints 
may reflect underlying depression and anxiety and not just cognitive impairment, 
(Stulemeijer, Vos, Bleijenberg, & Van der Werf, 2007). 
Factors that affect outcomes. 
Many variables can affect the outcomes of a MTBI including time post-injury, pre-
morbid status, recurrent injury, sociocultural and gender differences. 
 7 
Time post-injury.   
The typical clinical course of MTBI is the clearing of confusion within 24 hours, 
some initial impairment of memory and information processing, and executive 
dysfunction within the first 2 weeks and up to one month after injury (as detected by 
neuropsychological tests, Levin & Diaz-Arrastia, 2015; Theadom et al., 2016).  In most 
patients, symptoms gradually resolve during the following 12 weeks (Podell, Gifford, 
Bougakov & Goldberg, 2010; Ruff, 2005) with 80-85% of patients with an isolated MTBI 
having a favourable recovery within 3-6 months (Gentilini  Nichelli, Schoenhuber et al., 
1985).  There is evidence however that long-term physical, cognitive and affective deficits 
can occur in some individuals with MTBI (Clarke, Genat & Anderson, 2012). 
A prospective, longitudinal study found that 30% of patients with mild TBI had new 
onset or intensification of at least one post-concussion symptom 3 months after injury 
(Meares et al., 2011).  This is consistent with previous research by Lannsjö et al., (2009), a 
population-based large study (n = 2602) based on non-hospitalized mild TBI cases, which 
indicated the presence of one or more post-traumatic symptoms (as measured by the 
Rivermead Post-Concussion Symptoms Questionnaire - RPQ) at three months after injury in 
44% of the cases and three or more symptoms in 24% of the cases. Unfortunately, this study 
did not use a control group to compare with TBI-free participants and it is possible that post-
concussive-type symptoms are commonly experienced by the general population overall. 
 The BIONIC study found a longer-term trajectory for cognitive effects with over 
20% of people still experiencing difficulties with complex attention and memory at 12-
months post-injury (Barker-Collo et. al., 2015).  Between 27.3% and 47.9% of their 
longitudinal study participants experienced four or more mild to severe PCS at 12-months 
post-injury.   
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A substantial amount of research looking at outcomes from MTBI has focused on 
concussion which is one type of MTBI that is often sustained by athletes.  Athletes with 
concussion appear to have a more rapid recovery than those in the general population 
(McCrory, Meeuwisse, Aubry, Cantu & Dvorak, 2013) .  In concussion, there are differences 
in the loss of consciousness, comorbidities, and pre-injury disorders.  Many sports clinicians 
now use comprehensive TBI assessments such as the Sports Concussion Assessment Tool 
which includes a cognitive assessment, assessment of symptoms, loss of consciousness, GCS 
and a balance, neck and co-ordination examination. (Theadom et al., 2018).  These more 
complex assessments are too time-intensive for Emergency Departments and are not designed 
for the general public.  Head injuries sustained during sporting activity are therefore often 
more effectively identified in the acute phase than those sustained by the general public.  In 
comparison with patients with MTBI presenting to emergency rooms, post-concussion 
symptoms in 80–90% of adult athletes typically resolve within 7–10 days after their first 
concussion (McCrory, Meeuwisse, Aubry, Cantu & Dvorak, 2013).  The more mild effects of 
concussion could be due to the specialist medical attention and support that those who sustain 
a sports concussion commonly receive at the side-line at the time of injury whereas in the 
general population once a MTBI is sustained there is usually waiting time before medical 
assistance is received. 
  The timeline for symptom resolution after MTBI is therefore not a linear process 
with wide heterogeneity in terms of recovery even with similar injury profiles (Theadom et 
al., 2016).  The impact of MTBI on an individual’s ability to adapt to life changes will 
fluctuate and, in relation to affect changes for example, it cannot be assumed that someone 
who initially presents without depression or anxiety for example will remain free of these in 
the long-term as they continue to acclimatise to life after injury (Barker-Collo, et al 2018).   
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Pre-morbidity. 
Levin et al., (1987) concluded that a single uncomplicated minor head injury produces 
no permanent neurobehavioural difficulties in the majority of patients without pre-existing 
psychiatric disorder or substance abuse.  Levin’s conclusions are supported by Ponsford et 
al., (2012) who compared post-concussion symptoms of 123 patients with MTBI and 100 
trauma patient controls, both groups recruited from the emergency department, and found 
that, at 3 months post-injury, premorbid physical or psychiatric problems, but not MTBI, 
most strongly predicted continuing symptoms.  This concurs with Clarke et al. (2012) who 
concluded that 3-12-month post-concussive symptoms (physical, affective and cognitive) 
were principally characteristics of psychological symptoms (depression, anxiety and 
neuroticism) and not of brain damage.  Another prospective, longitudinal study (Ponsford, 
Cameron, Fitzgerald, Grant & Mikocka-Walus, 2011) indicated that a pre-
injury neuropsychiatric disorder is strongly related to persistence of symptoms for 3 months 
or longer after MTBI.   
Recurrent TBI. 
There have been limited studies on the frequency or impact of recurrent TBI within 
the general population.  Although a meta-analysis by Belanger, Spiegel & Vanderploeg 
(2010) highlighted inconsistent findings overall about the impact of recurrent TBI, their 
follow-up analysis revealed poorer outcomes from multiple MTBI.  A more recent 
population-based study on recurrent TBI incidence and outcomes over a one year period 
(Theadom et al., 2015) identified participants from the original BIONIC study, which was 
carried out between 2010-11 and that examined the incidence and outcomes (up to 12-
months) of TBI across all age groups (Feigin et al., 2013).  Those who had sustained a 
recurrent brain injury within one year following their initial index injury were  matched to a 
comparison group from within the study, based on age (+ 2 years) and gender, who had only 
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sustained the one index injury.  A high proportion of these recurrent TBI’s were classified as 
mild.  Outcomes measured were post-concussion symptoms, cognitive impairment and 
disability.  Theadom and colleagues found that 9.9% of their study participants (n=72) had 
experienced recurrent TBI, higher than previous empirical estimates of 7-9% over a 6-7 year 
period (Theadom et al., 2015).  Recurrent TBI cases reported significantly increased 
frequency and severity of PCS at 1 year, compared to the matched controls sustaining one 
TBI. There was no difference in overall cognitive ability and disability between the two 
groups (Theadom et al., 2015).   
Sociocultural factors. 
Ethnic minorities may be at higher risk of TBI.  In New Zealand the total incidence of 
TBI within Māori populations was found to be significantly higher compared to all other 
ethnic groups (1206/100,000 compared to 887/100,000 for Europeans, Feigin et al., 2013).  
This was mainly due to a higher TBI incidence in Māori people older than 35 years compared 
to those in the same age range of other ethnicities.  Compared with Europeans, Māori people 
had a greater risk of MTBI (RR 1.23, CI 1.08-1.39) and poorer cognitive outcomes which 
were related to social and socio-economic factors, lower educational levels, emotional 
distress (such as depression) and poorer physical functioning 6-months post-MTBI (Barker-
Collo et al., 2015).  Non-white ethnic group was associated with poorer outcomes at 12-
months post-injury (Theadom et al., 2016). 
The majority of TBI’s are mild and although symptoms and outcomes can be difficult 
to detect, they can be persistent and debilitating.  Many factors can affect the recovery 
trajectory of MTBI, including time post-injury, pre-morbid functioning, recurrent injury and 
sociocultural factors.  Gender may also influence the outcome of a MTBI but this relationship 
has not been well studied outside of the sports athlete domain which does suggest some 
gender differences. 
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Gender differences in outcomes of MTBI. 
In a literature review investigating sex, gender and intersecting vulnerabilities in 
relation to TBI in general, Mollayeva, Mollayeva & Colantonio, (2018), concluded that many 
interacting factors, including sex and gender, can modify the structural and functional 
outcomes of TBI.  The authors found that males and females exhibited biological differences 
that could affect injury perception, communication, motivation, memory and aggressive 
behaviour.  Additionally, they discovered a complex array of factors, linked to gender 
inequalities, such as access to health services, economic opportunities, relationships, gender 
roles and capacity for personal development that could determine gender differences in TBI 
outcomes. 
It has been observed that in 40% of those admitted to hospital and undergoing a CT 
scan within 24 hours of sustaining a TBI, changes take place in the brain that may make the 
patient prone to developing hormone deficiencies and this may explain gender differences in 
outcomes from MTBI.  However, a study by McCauley, Boake, Levin, Contant & Song, 
(2001) found no significant gender differences in post-injury symptoms (as per DSM-IV 
post-concussional disorder symptoms which include tiring easily, disordered sleep, 
headaches, vertigo/ dizziness, irritability, anxiety/ depression/ affective lability, changes in 
personality, or apathy) between a general trauma group (TBI-free) and a group 3 months 
post-MTBI. 
A systematic review of sex differences in sports-related concussion by Solomito, 
Reuman & Wang, (2019) identified differences in brain structure between sexes with the 
corpus callosum in males to be larger, more fibrous compared to females and concluded that 
males tend to use one hemisphere of their brains for most tasks whereas females utilise both 
hemispheres.  Their final analysis was that, because of these differences, strain injury of the 
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corpus callosum may affect females to a greater degree than males as their ability to process 
information may become more disrupted following MTBI. 
Mild TBI often goes unreported to the medical profession as its felt effects can be 
minimal in the acute phase and the reporting of symptoms is the first step in identifying the 
outcomes and course of MTBI.  As such, there may also be gender differences in the level of 
symptom-reporting following a MTBI, due to both the degree of knowledge and awareness 
around injury-relevant symptoms and the associated risks, and also to gender-related reasons 
for not reporting symptoms to a medical professional or authoritative figure.  Miyashita,  
Diakogeorgiou & Vandervegt, (2016), found gender differences in concussion reporting 
among high school athletes with female athletes significantly more likely to report a 
concussion than their male colleagues. These results raise the issue of possible under-
reporting by men, either due to different norms and expectations in their sports, or due to 
issues related to their gender identity.  This is also of concern as males have an increased risk 
of TBI at all ages compared to females (Saunders, et al., 2009). 
Wallance, Covassin & Beidler, (2017) conducted a cross-sectional survey of 288 
high-school athletes’ knowledge of sport-related concussion symptoms and their reasons for 
not reporting them.  The researchers found that males and females had similar symptom 
knowledge but that females were more likely to report their concussive symptoms to an 
authoritative figure.  Chi-square tests identified significant relationships between sex and 
eight reasons for not reporting a concussion.  Males were less likely to report their symptoms 
due to thoughts that their coach would get mad, their teammates and coach would think they 
were weak, their parents would be upset or because it was the end of the season and they did 
not want to miss a game or lose playing time and they did not want to let their team down.  
These reasons for not reporting a concussion reflect a focus from the individuals on the 
reactions and perceptions of others rather than on internal factors and may indicate a fear of 
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being stigmatised for seeking help and therefore more concerned than females about their 
image and their reputation on the team.  Males were 4 to 10 times more likely not to report 
concussion symptoms because they did not want to lose playing time and this could support 
stereotypical male gender norms of “sucking it up” or playing through the pain due to 
pressures to win games.   
This is consistent with research by Gaudet et al., (2018) which found that, based on 
self-reported and objective outcomes, females’ usual daily activities were more affected by 
MTBI and post-concussion symptoms than men.  Studies have also found that male and 
female athletes exhibit differences on baseline (pre-concussion) neuropsychological test 
performance and concussion symptoms and that they may also demonstrate sex differences 
on post-concussion test scores and symptom reporting.  Female athletes reported higher 
symptoms prior to concussion than males, and females were more likely than males to 
endorse mild degrees of headache, fatigue, irritability, sadness, nervousness, feeling more 
emotional, feeling slowed down and difficulties with sleep and concentration at pre-injury 
(Iverson and Stearne, 2006).  These findings had small-to-medium effect sizes.   
Whilst there are an array of symptoms that can present following MTBI, a lesser-
researched area of symptomatology after MTBI is in relation to gender differences in longer-
term depression and anxiety outcomes and this is the focus of my study.  A definition of 
depression and anxiety and their epidemiological factors in the general population is provided 
followed by a more detailed literature review of the trajectory of depression and anxiety 
following MTBI and associated gender differences.  Depression will be documented first, 
followed by anxiety.   
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Depression 
Worldwide projections by the World Health Organization for the year 2030 identify 
unipolar major depression as the leading cause of disease burden.  Depressive disorders are 
characterised by the presence of sadness, emptiness, hopelessness and irritability, 
accompanied by somatic and cognitive changes that significantly affect the individual’s 
ability to function, such as concentration problems, fatigue, loss of interest in previously 
enjoyed activities, disturbances in appetite, weight and/or sleep and often recurrent thoughts 
about death or suicidal ideation (American Psychiatric Association, 2013).  The mortality risk 
for suicide in depressed patients is more than 20-fold greater than in the general population 
with over half of all suicides occurring within the context of a mood disorder 
(Guillamondegui et al., 2011).  The manifestations of depression may differ in duration, 
timing, or aetiology and can range from mild to full impairment, such as the incapacity for 
basic self-care.  Major depressive disorder is characterised by discrete episodes of at least 2 
weeks’ duration involving clear changes in affect, cognition, autonomic nervous system 
function and inter-episode remissions.  Diagnostic criteria include five, or more, symptoms 
present for at least 2 weeks and including depressed mood or loss of interest or pleasure.  A 
more chronic form of depression, persistent depressive disorder, can be diagnosed when the 
mood disturbance continues for at least 2 years in adults and includes the presence of poor 
appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor 
concentration or difficulty making decisions and feelings of hopelessness. 
In the New Zealand Mental Health Survey (2006) the lifetime prevalence of 
depression has been reported as 20.2% (CI 95% 19.3 – 21.1). The 12-month prevalence 
of mood disorder was 7.9% (CI 95% 7.3-8.7) for the total New Zealand population, with 
decreasing prevalence with increasing age, and higher prevalence in females (8.1% versus 
4.9% in males) (Scott, Oakley Browne & Wells, 2010).  Depressive disorders, as defined by 
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the World Health Organisation, have a 12-month prevalence which varies from 3% in Japan 
to over 9% in the United States (Demyttenaere et al., 2004). Greater severity of depressive 
symptoms has been found to be associated with significantly higher risk of all-cause 
mortality including cardiovascular death and stroke as well as with diabetes and obesity.  
Depression can disturb many life domains, including  physical, emotional, social 
wellbeing and professional competence.  It is also is also a huge burden for both the 
family of the depressed patient and for society at large.  Depression increases the 
risk of diminished workplace productivity and has been estimated to result in a loss of $36.6 
billion per year in the United States of America ($USD).  Depression is often a chronic and 
relapsing condition (Oquendo et al., 2013). 
Heritability estimates of major depression of 40% suggest that environmental 
experiences are the major contributor to risk (Sullivan, Neale & Kendler, 2000) and these risk 
factors may include experiencing adverse events during childhood such as emotional, 
physical and/or sexual abuse (American Psychiatric Association, 2013). The somatic 
consequences of depression could partly be due to metabolic, immuno-inflammatory, 
autonomic and hypothalamic-pituitary-adrenal (HPA)-axis dysregulations which have been 
consistently observed among depressed patients (Penninx, Milaneschi, Lamers & 
Vogelzangs, 2013).  
Sociocultural differences in depression.   
There are documented cultural/ethnic differences in the rates and symptom expression 
of depression.  Dunlop et al., (2003) found that higher depression rates among minority 
individuals were largely associated with greater health burdens and lack of health insurance.  
Dreher et al., (2017) discovered differences in the cultural dynamics of symptom presentation 
in people with depression; for example, Vietnamese patients presented with more somatic 
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symptoms than German patients.  Kwon, Yoon, Joormann & Kwon (2013) found cultural 
differences in the depression-associated emotional regulation strategies used by American 
and Korean adults.   
Gender differences in depression.   
In the general population, females are 70% more likely to experience depression than 
males (National Alliance on Mental Illness, 2016), particularly during the reproductive years, 
and women can often present differently to males with depression.  Explanations for this 
higher prevalence are inconclusive but include psychological, neurochemical, anatomical, 
hormonal, genetic and personality factors (Bremner et al., 2002; Grigoriadis & Robinson, 
2007).  One theory is that females are more prone to the effects of stress and there is a strong 
positive relationship between stress and depression (Davidson et al., 2002; Nemeroff & Vale, 
2005) and depression is a common response to stress (Kendler & Gardner, 2000).   Stressors 
can cause long-term dysregulation of the HPA axis (Heim & Nemeroff, 2001) which has also 
been observed by Penninx et al., (2013).  There is also a view by some researchers that the 
DSM-5 (American Psychiatric Association (APA), 2013) used to diagnose psychiatric 
conditions, includes depressive symptoms that are more easily observed in female-specific 
depression (Lavoie et al., 2017). Women are also at greater risk for relapse as compared to 
men (Oquendo et al., (2013) within a two year period. 
Women with depression report more somatic symptoms, including pain, than do men 
(Silverstein et al., 2013).  Iverson and Stearne, (2006) found in a study of college athletes that 
female athletes reported higher symptoms at baseline than males and that females were more 
likely than males to endorse mild emotional symptoms such as irritability and sadness, at 
baseline neuropsychological assessment.  Although not conclusive, these data may suggest a 
stronger likelihood for females to endorse greater depression symptomology than males at 
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baseline.  Males may be under-reporting and females may be accurately reporting or perhaps 
females are more willing to report affect symptoms than males in general.   
Anxiety 
Anxiety disorders are characterised by excessive fear and anxiety and related 
behavioural disturbances.  Fear is the emotional response to real or perceived imminent 
threat, whereas anxiety is anticipation of future threat.  Fear is more often associated with 
surges of autonomic arousal necessary for flight or flight, thoughts of immediate danger and 
escape behaviours, and anxiety is more often associated with muscle tension and vigilance in 
preparation for future danger and cautious or avoidance behaviours.  Whilst anxiety is a 
normal physiological state, an anxiety disorder develops when the fear or anxiety becomes 
excessive or persisting, typically, for 6 months or more and causes clinically significant 
distress or impairment in social, academic, occupational or other important areas of 
functioning (APA, 2013).  Anxiety disorders featured in the DSM-5 include social anxiety 
disorder, panic disorder and generalised anxiety disorder.  The New Zealand Mental Health 
Survey (Wells et al., 2006) has reported the lifetime prevalence of anxiety (all types) to be 
24.9% (CI 95% 23.6 – 26.2) and the 12-month prevalence to be 14.8% (CI 95% 13.9 – 15.7).  
Prevalence estimates for anxiety disorders vary across countries, with 12-month prevalence 
ranging from 2·4% (Italy) to 29·8% (Mexico) and prevalence in the U.S.A and European 
countries tends to be higher than in the rest of the world, (Craske & Stein, 2016). 
 Anxiety disorders are often co-morbid with major depression and if left untreated can 
become chronic.  Impairment and disability associated with anxiety disorders might be 
greater for women than for men and adverse childhood experiences (e.g., childhood abuse), 
parents with a history of  mental disorders, low socioeconomic status, and an overprotective 
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or overly harsh parenting style are also risk factors for anxiety disorders (Craske & Stein, 
2016). 
The heritability of anxiety disorders is estimated to be in the range of 30-50% 
(Shimada-Sugimoto, Otowa & Hettema, 2015).  The pathophysiology of anxiety disorders is 
poorly understood but accepted hypotheses include overgeneralisation of conditioned fear 
and deficits in the extinction of conditioned fear (Craske & Stein, 2016).   Brain imaging, 
including functional Magnetic Resonance Imaging (MRI), suggest that anxiety is 
characterised by limbic region overactivity during emotional stimulation and deficits in 
functional connectivity in this and other regions of the brain  (Fonzo et al., 2015). 
Sociocultural differences in anxiety.   
Differences have been found in the prevalence and severity of anxiety in African 
Americans and European Americans, (Hopkins & Shook, 2017).  A number 
of sociocultural risk and protective factors have been suggested to contribute to these 
group differences in anxiety including ethnic identity and stigma toward mental illness  
which consistently differed by racial group and were associated with anxiety in African 
Americans. Ethnic identity may buffer against the negative consequences of anxiety, 
reducing prevalence rates in African Americans or stigma toward mental illness may decrease 
African Americans’ willingness to report anxiety symptoms, reducing overall prevalence 
rates but increasing the severity of treated cases, (Hopkins & Shook, 2017).  
In a study of Latino participants, results indicated that the interaction between anxiety 
sensitivity and subjective social status was significantly associated with the number of mood 
and anxiety disorders, panic, social anxiety, and depressive symptoms, (Zvolensky et al., 
2015).    
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Gender differences in anxiety.  
 Females have a higher, (approximately doubled), prevalence of anxiety symptoms 
and anxiety disorders compared to males and the causal mechanisms for this remain 
inconclusive (Faravelli, Scarpato, Castellini & Lo Sauro, 2013).  This greater female 
prevalence of anxiety disorders could be due to differences in gender socialisation and 
mastery learning experiences, where the indirect effects of gender on anxiety via 
instrumentality and mastery were both significant in a cross-sectional, not causal, study of 
398 undergraduate students (Zalta & Chambless, 2012).  These findings were consistent with 
theories that gender differences in anxiety are associated with socially-constructed and 
reinforced gender roles and learning experiences for men and women, including perceived 
societal norms such as rewarding boys for assertiveness, more controlling parenting styles for 
girls, higher expectations of boys and different tolerance levels of specific emotions between 
the sexes.  Males and females may also show different environmental risk factors such as 
childhood trauma, psychosocial and economic factors (Oldehinkel & Bouma, 2011).  The 
higher prevalence of anxiety in females is a trend that persists until middle age (mid-fifties) 
and then declines once post-menopausal (Cairney & Wade, 2002; Leach, Christensen, 
Mackinnon, Windsor & Butterworth, 2008; Bijl, De Graaf, Ravelli, Smit & Vollebergh, 
2002).  This could suggest that hormones are a factor in the prevalence of anxiety in females 
and in support of this hypothesis, Faravelli et al., (2013) found that the risk of the onset of 
anxiety after menopause was similar in both genders.  
Gender differences in DSM-IV anxiety disorders were examined in a large sample of 
adults (N = 20,013) in the United States of America using data from the Collaborative 
Psychiatric Epidemiology Studies (CPES). Women had higher rates of lifetime diagnosis for 
each of the anxiety disorders examined which were also associated with a greater illness 
burden in women than in men, particularly among European American and Hispanic women. 
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These results suggest that anxiety disorders are not only more prevalent but also more 
disabling in women than in men. (Mclean, Asnaani, Litz, & Hofmann, 2011). 
There is some evidence to indicate that men tend to underreport anxiety symptoms 
(Pierce & Kirkpatrick, 1992 in Zalta & Chambless, 2012).  Iverson and Stearne, (2006) found 
in a study of college athletes that female athletes reported higher symptoms at baseline than 
males and that females were more likely than males to endorse mild emotional symptoms 
such as nervousness at baseline neuropsychological assessment.  Further studies have 
concluded that other (sociocultural) factors and not just reporting biases account for gender 
differences in anxiety (Mclean & Hope, 2010).  However, it cannot be ruled out that the 
observed differences between men and women are somewhat influenced by gender-related 
differences in the conceptualization and reporting of symptoms (Mclean et al., 2011). 
Co-morbid Depression and Anxiety  
There is a high level of co-morbidity between depression and anxiety and a co-morbid 
presentation increases the risk of a poorer outcome in terms of prognosis (Bruce et al., 2008 
& Merikangas et al., 2003).  The National Comorbidity Survey Replication (2012) projected 
that between 5% and 9% of the adult population in a 12-month period would have co-morbid 
depression and anxiety (Gadermann, Alonso, Vilagut, Zaslavsky & Kessler, 2012). 
Penninx et al., (2011) compared the 2-year course of depressive and anxiety disorders 
within the same study design and with the same instruments, namely the DSM-IV based 
Composite Interview Diagnostic Instrument and Life Chart Interview (n = 2981).  The 
prevalence of co-morbid depression and anxiety was 37.6% and the index episodes of this 
group were more severe and chronic with an earlier age of onset and with a more frequent 
treatment regime.  Penninx et al., (2011) found that depression and anxiety have a different 
naturalistic course trajectory in terms of recovery and duration (with worse outcomes for 
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anxiety) and concluded that separate consideration should be given to each disorder in 
clinical practice to achieve optimum outcomes. 
The majority of TBI are mild and, to date, long-term outcomes of MTBI have not 
been adequately documented and this restricts the effective and efficient provision of 
healthcare to this population.  It is known that depression and anxiety are commonly 
experienced following a TBI (Barker-Collo et. al., 2015) but the full burden of these 
disorders, and the interaction with gender, is undetermined. 
MTBI and Depression 
There is much variability in reports of the prevalence of depression after MTBI and it 
ranges from 12% to 44% in the first 3 months (Waljas et al., 2015; Mooney & Speed, 2001; 
Levin & Diaz-Arrastia, 2005) to between 8% to 70.1% in the first year post-MTBI (Barker-
Collo et al., 2015; Scholten et al., 2016; Wood, 2004; Rapoport, McCullagh, Streiner & 
Feinstein, 2003 and Bombardier, Hoekstra, Dikmen & Fann, 2016).   This variability was 
highlighted by Kreutzer, Seel and Gourley, (2001): who stated ‘…despite researchers best 
efforts, the brain injury rehabilitation community has been provided with disparate, 
incomplete and inconsistent information about depression’ (p. 563). The average prevalence 
of depression after MTBI of 31.7% was calculated from over 100 studies by Guillamondegui, 
et al., 2011.  This extensively-reported variability in depression prevalence following MTBI 
is due to methodological differences between studies, including variances in sample 
populations and measures of depression.  There is also variability in the exact direction in 
which depression changes after MTBI: many studies report a drop in depression, a stable rate 
over time and some propose an increase (Wood, 2004).   Others suggest a variable and non-
linear direction (Barker-Collo et al., 2018).  Compared to a lifetime prevalence of depression 
in New Zealand of 20.2% and a 12-month prevalence of mood disorder in New Zealand of 
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7.9% (CI 95% 7.3-8.7), empirical findings may suggest that there is an increased risk of 
developing mood disorders after MTBI. 
Kontos, Covassin, Elbin & Parker, (2012) concluded that, although not clinically 
significant, athletes experienced statistically significant increased depression scores on the 
Beck Depression Inventory-II (BDI-II) up to 14 days after concussion injury (measures at 
baseline, 2 days and 7 days).  Depression was found to be related to post-concussion 
symptoms at both one month and one year following MTBI in 126 adult participants, 
recruited from an emergency department in Finland and compared with an age- and sex-
matched control group with no history of head injury or psychiatric disorders, (Waljas, et al., 
2015.  The scales used by Waljas et al., 2015 to measure depression were the BDI-II (a more 
somatic measure of depression than the HADS) which was adjusted to ensure specific 
differentiation between depressive and post-concussive symptoms.   The researchers found 
that the MTBI participant group reported more depressive symptoms at one month post-
injury compared with controls but this was not statistically significant and the groups did not 
differ in depressive symptom reporting at the one year point.  They found a sub-group of 
MTBI patients who had endorsed an extremely high number of post-concussion symptoms 
(>11 on the RPQ) at 1-month and 1-year post-injury but none of the control participants did 
so and this could suggest that some MTBI patients have persistent post-injury issues. 
As part of the BIONIC study of depression after 1-, 6- and 12- months after MTBI, 
Barker-Collo et al., (2015) found that, although depression symptoms did commonly occur, 
the average total depression scores on Hospital Anxiety Depression Scale (HADS) depression 
items for their sample (n=315) were quite low at each assessment (subclinical) and they 
significantly decreased over time.  The most commonly-reported depression-related symptom 
was a “feeling of being slowed down” (which is also a common sequelae of PCS).  The 
authors found that the levels of depression throughout the same timepoints were comparable 
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with the general population. Within 2 weeks (baseline) of injury 21% of their sample met 
criteria for depression (HADS >8) but by one month following injury this had reduced to 
17.1% and this downward trajectory continued at 6 months (15.7%) and 12-months (12.4%) 
post-injury.  The HADS total depression mean scores followed the same pattern: 4.73 at 
baseline and significantly decreasing to 3.48 at 12-months post-injury.  Of the individuals 
who met HADS criteria for depression at baseline, 35.7% continued to meet criteria at 12-
months.   Of those not presenting with depression at baseline (n=122), 3.2% met criteria for 
depression at 12-month follow-up.   
The SHEFBIT study (Sheffield Brain Injury after Trauma) by Singh, Mason, Lecky & 
Dawson (2019), studied 774 individuals with TBI, which included a high proportion of MTBI 
participants (44.8%).  They reported a prevalence for depression at 10 weeks of 56.3% [95% 
CI 52.8-59.8] using a HADS cut-off of >8 which reduced at 12-months to 41.2% [95% CI 
37.6-44.9].  In the same study, at the higher cut-off of HADS >11, depression was 17% at 12-
months post-TBI and had reduced from 29.2% at 10 weeks post-injury.  Many of the 
participants with initial depression at 10 weeks had it resolved by 12-months (35.2%) but 
89% of those with depression at 12-months had also been depressed at 10 weeks.  A small 
number (10.9%) of those with depression at 12-months had not shown depression symptoms 
at 10 weeks. This shows some fluctuation of depression over time.  
Utilising the Structured Clinical Interview for DSM (SCID), the Centre for 
Epidemiological Studies – Depression Scale (CES-D) and the Visual Analogue Scale For 
Depression (VASFD), McCauley et al., 2001 found different prevalence levels of major 
depression disorder (MDD) between a general trauma (TBI-free) group and a MTBI group 3-
months’ post-injury: 16.5% compared to 21.4% for the MTBI group.  Schoenhuber and 
Gentilini (1988) examined 35 MTBI patients from 5 to 17 months post-injury and compared 
them to a control group (TBI-free) on the Self-Rating Depression Scale and the State-Trait 
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Anxiety Inventory.  Those with MTBI were at greater risk of developing depression (p = 
0.003) and 39% of the MTBI patients reported depression symptoms at 1 year post-TBI. 
To study even longer-term effects of MTBI on depression, Barker-Collo et al., (2018) 
extended the authors’ previous 2015 study to 48 months using the same population sample (n 
= 341). Total mean scores on the HADS depression scale significantly decreased from 
baseline (2 weeks) over the 48-month follow-up periods.  However, the proportion of their 
population sample meeting HADS (>7) criteria for depression increased to 7.7% at 48 
months compared to 2.2% at 12-months post-injury suggesting that the level of depression 
increases for some people in the longer-term. 
Scholten et al., 2016 examined pre- and post-injury prevalence of SCID diagnosed 
depressive disorders after all severities of TBI.  Their systematic literature search included a 
total of 34 studies: pooled prevalence estimates of depressive disorders increased over time 
and indicated high long-term prevalence of 43% for depression (after average follow-up 
periods of between 1.5 – 5 years).  Long-term prevalence rates were almost all greater than 
(or equal to) the rates before TBI in all studies that measured both pre-injury and long-term 
prevalence.   
Konrad et al., (2011) studied 33 participants who had sustained MTBI on average 6 
years prior and matched these to healthy controls by age, gender and education.  The 
researchers assessed psychiatric symptoms via a structured clinical interview for DSM-IV 
(SCID-1) and the Beck Depression Inventory (BDI).  The BDI scores were significantly 
higher in the patient group, and three patients fulfilled DSM-IV criteria for a mild episode of 
major depression.  They concluded that long-term emotional sequelae continue even after 6 
years post-injury.   
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In summary, in the acute phase of MTBI, mean scores for depression have been 
reported to significantly increase in the first 14 days (Kontos et al., 2012) and then to 
significantly decline to 48 months post-injury (Barker-Collo et al., 2018), although these 
scores were not within clinical ranges.  In some studies the prevalence of depression is higher 
and decreases over time (from 56.3% to 41.2% and from 21% to 12.4% from baseline to 12-
months post-injury) and in others the prevalence is lower and increases over time (2.8% to 
7.7% at 48 months).  Long-term prevalence for depression has been reported as between 9% 
and 43% for on average 1.5 – 6 years post-injury.  However, Barker-Collo et al., (2015) 
found that the levels of depression throughout 1, 6 and 12-month timepoints were comparable 
with the general population. 
MTBI and Anxiety 
A literature review by Moore, Terryberry-Spohr & Hope, 2006 noted significant 
evidence that MTBI can give rise to the manifestation of anxiety and that anxiety symptoms 
may severely impact the prognosis and recovery course from MTBI. This contrasts with other 
research that demonstrated no differences between HADS anxiety scores between MTBI 
patients and 100 trauma controls at acute assessment, 1 week and 3 months post-injury 
(Ponsford et al., 2012).  Research by Singh, Mason, Lecky & Dawson, 2019 who studied all 
severities of TBI (with nearly 45% MTBI), showed a reduction from 63% to 42.3% of 
participants on measures of anxiety (HADS >8) between the 10 week and one year post-
injury follow-up. At the higher cut-off of HADS >11, anxiety was reported in 21.6% of 
participants at 1 year post MTBI.    Barker-Collo et al., (2015) found that anxiety, as 
measured by the HADS (cut-off >8), was experienced by 42.2% of participants at baseline 
and decreased to 30% by 1-month post-MTBI.  At 6 months post-MTBI the prevalence of 
anxiety increased slightly to 33.2% and decreased slightly at 12-months to 29.3%.  The mean 
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anxiety scores on the HADS (cut-off >8) increased significantly from baseline to 1-month 
and overall from baseline to 12-months with a significant change reflected in the decrease in 
anxiety scores from 6 to 12-months.  The mean level of anxiety peaked at 6 months post-
MTBI, suggesting that anxiety difficulties are more prominent within the first 6 months post-
injury. Barker-Collo et al., (2015) concluded that levels of anxiety found post-TBI across the 
follow-up periods were comparable to the general population. 
Schoenhuber and Gentilini (1988) examined 35 MTBI patients from 5 to 17 months 
post-injury and compared them to a control group (TBI-free) on the Self-Rating Depression 
Scale and the State-Trait Anxiety Inventory.  Those with MTBI were at no greater risk of 
developing anxiety than the control group and 26% of MTBI patients reported anxiety after 1 
year. 
In terms of the longer-term trajectory for anxiety following MTBI, Scholten et al., 
2016, in their literature search of all-severity TBI, indicated high long-term prevalence of 
36% for anxiety (after average follow-up periods of between 1.5 – 5 years).  The authors 
found that long-term prevalence rates were almost all greater than (or equal to) the rates 
before TBI in all studies that measured both pre-injury and long-term prevalence.  In contrast, 
with a focus on MTBI, Barker-Collo et al., (2018) found in the BIONIC study that total 
scores on the HADS anxiety scale decreased significantly over the 48-month follow-up 
periods.    At baseline, the prevalence for anxiety, using a HADS clinical cut-off score of 7, 
was at its highest with 29.5% of the sample, dropping to 13.6% at 48 months. 
Compared to the New Zealand Mental Health Survey (Wells et al., 2006) figure for 
the 12-month prevalence of anxiety disorder of 14.8% (CI 95%, 13.9-15.7), Barker-Collo et 
al., (2018) showed a variable post-TBI anxiety prevalence of between 3.7-29.5% suggesting 
that the presence of TBI may increase the risk of anxiety.   
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MTBI and Comorbid Depression and Anxiety 
Depression and anxiety have an extremely high comorbidity rate (Alway, Gould, 
Johnston, McKenzie & Ponsford, 2016) and Singh, Mason, Lecky & Dawson, (2019) found 
that over 90% of their study sample population who classified as having depression 
(HADS >8) also had comorbid anxiety at 10 weeks post-TBI.  At 1 year this prevalence 
decreased to 42.3% and at the higher cut-off of >11 on the HADS, comorbid anxiety was at 
21.6% at 1 year.  Penninx et al., (2011) found a 37.6% 2 year prevalence of comorbid 
depression and anxiety as measured by DSM-IV.  This has been supported by Barker-Collo et 
al., 2018 findings that anxiety or a combination of anxiety and depression was much more 
common than depression alone after MTBI injury across timelines (2 weeks, 6, 12 and 48 
months) with comorbidity rates ranging from 10.2% to 20.7% over the first year post-injury.  
At baseline co-morbid prevalence was 20.7%, decreasing across the 6-month and 12-month 
timepoints to 15.7% and 10.2% respectively and remaining at 11.8% at 4 years post-injury, 
higher than that of between 5% and 9% of the adult population in a 12-month period which 
has been projected by The National Comorbidity Survey Replication (Gadermann et al., 
2012). 
Predictors of Depression and Anxiety post-MTBI 
As with other post-concussion symptoms, the cause of persistent mood symptoms 
following MTBI is diverse, multifactorial and individualised, and a biopsychosocial 
perspective in understanding the cause of these symptoms is useful. With regard to injury and 
demographic features which may predict depression risk at 1 year, literature reviews have not 
found one consistent feature that is associated with this risk (Singh, Mason, Lecky & 
Dawson, 2019).  Chronic depression and anxiety symptoms can arise from both the 
physiological effects of trauma to the brain and as a result of psychological distress 
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associated with altered functional ability and changes in quality of life.  An accepted 
hypothesis is that prefrontal dysfunction affects emotional regulation and high levels of 
amygdala activation may be associated with an increase in anxiety symptoms and negative 
affect (Davidson, Pizzagalli & Nitschke, 2002), which together with the distress of sustaining 
a TBI, may explain persistent symptoms (Vasterling & Dikmen, 2012). Theories suggested 
by Silverberg & Iverson (2011) and Moldover, Goldberg & Prout (2004) posit that longer-
term depression and anxiety symptoms, are impacted by pre-morbid personality traits, coping 
mechanisms, post-injury support mechanisms and other psychosocial features. 
In terms of pre-morbid psychiatric difficulties as a risk factor for depression and 
anxiety post-MTBI, Barker-Collo et al., (2015) found that there was a significant correlation 
between those who met criteria for depression at 12-months post-injury and a self-reported 
pre-morbid history of depression (35.9% of depressed subjects vs. 18.8% of non-depressed 
subjects), a history of anxiety and greater age at the time of injury.  Whilst those with a pre-
injury history of mental health difficulties were more likely to have post-concussion 
symptoms at one month, but not at one year, post-concussion symptoms were significantly 
correlated with depression symptoms at both one month and one year following injury 
(Waljas, et al., 2015).  Singh et al., (2019) analysed pre-morbid self-reports of a history of 
depression and found that predictors of 1-year depression were an abnormal CT scan, past 
psychiatric history, alcohol intoxication and female gender.  However, Scholten et al., (2016) 
found that 35.8% of those with a pre-injury mood disorder presented post-injury with an 
additional novel diagnostic class of mood or anxiety disorder and findings of mood and 
anxiety post-injury often presented without a pre-injury disorder (35.8% depression, 31.8% 
anxiety).   
With regard to injury severity as a predictor of depression, Singh et al., (2019) found 
that at 1-year post-injury, TBI severity, age, aetiology and medical comorbidity were not 
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significant predictors whereas at 10 weeks post-injury, increased severity and CT findings 
were highly significant. In Barker-Collo et al., (2015) levels of injury severity, impairment 
and functioning did not appear to be related to developing major depression at 1-year 
(Barker-Collo et al., 2015 and Seel & Kreutzer, 2003) and nor did the type of injury (e.g., 
close, penetrating, diffuse or focal injury, Rapoport et al., 2003; Jorge 2004).     
Other predictor factors of mood disorder post-MTBI include being female and being 
without employment (Scholten et al., 2016; Singh et al., 2019).  However, Theadom et al., 
(2016) found that, whilst being female was a significant predictor of a poorer outcome on 
post-concussion symptom measures including HADS, levels of anxiety and depression were 
comparable with the general population.   
The predictors of depression and anxiety after MTBI are not conclusive as research 
findings are mixed and many different individualised factors can make a person more 
vulnerable after injury, including the physiological effects to the brain, adapting to lifestyle 
changes, personality, premorbidity and significant life events.  Female gender has also been 
found to be a common predictor of depression among MTBI patients but this is no different 
to the general population where more females than men overall tend to report depression 
symptoms.    
Gender Differences in Depression and Anxiety post-MTBI  
Understanding the relationship between gender and depression and anxiety symptoms 
following MTBI is important in planning rehabilitation and intervention strategies in the 
long-term, but relative to the literature available on traumatic brain injury outcomes, there is a 
dearth of research about this area in clinical populations, and the various conclusions are 
mostly based on findings from the sports-concussion literature utilising a number of varied 
measures for depression and anxiety symptoms. 
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Kontos et al., (2012) examined depression symptoms (using the Beck Depression 
Inventory II) at 2-, 7- and 14-days following sports concussion and found that sex did not 
influence post-MTBI depression levels.  In concurrence with these findings, a study of a 
university student population, by Hurtubise, Hughes, Sergio & Macpherson (2018), did not 
find any clinically significant differences between genders in SCAT3 scores (Sport 
Concussion Assessment Tool 3) which includes measures of affect, taken within 48 hours of 
injury. Sex differences were found in post-concussion symptoms in college athletes in the 7-
10 days post-injury in that concussed men were significantly more likely than concussed 
women to report sadness on the Immediate Post-concussion Assessment and Cognitive Test 
(ImPACT) (p = 0.017), (Covassin, Schatz & Swanik, 2007).  In contrast, Baker et al., 2015 
found, from a sample of 147 student athletes with sports concussion, aged 13 to 19 years, that 
females reported significantly higher scores for seven depression symptoms, up to 3 months 
post-injury, which included affective symptoms such as feeling slowed down (p < .03), more 
emotional (p < .002), irritability (p < .03), and sadness (p < .04).  In concurrence, the study of 
690 emergency department admissions (of all TBI severities and ages), demonstrated that 
female gender was an independent predictor of depression at 10 weeks and at 1 year 
following a TBI, using the HADS (>8), (Singh et al., 2019).   
In terms of longer-term analysis of gender differences, there is some evidence that 
females have a higher prevalence of depression and anxiety symptoms post-MTBI.   Farace 
& Alves (2000) conducted a metanalyses of sex differences in TBI outcomes which focused 
on all severity levels from 6-months to 6-years after TBI, and included eight studies.  The 
authors demonstrated a significant difference, (effect size = 0.15), between genders and found 
that women demonstrated a worse outcome than men in 85% of the variables evaluated, 
including somatic/post concussive complaints, return to work, and new psychiatric symptoms 
including depression and anxiety.  In their systematic review of 37 MTBI studies ranging 
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from baseline to 11 years post-injury, Merritt, Padgett & Jack, (2019) found that females 
reported greater overall symptoms than males in psychiatric domains including fatigue, sleep 
difficulties, irritability, sadness, nervousness, feeling more emotional, feeling slowed down, 
difficulty concentrating, and difficulty remembering.   
In a prospective cross-sectional cohort study including 172 MTBI patients (out of 242 
TBI patients overall), after 6 months post-injury a higher percentage of women (45% vs. 
13%, p = 0.01) with MTBI were depressed compared with men (HADS >7).  A higher 
percentage of women also had an incomplete return to work compared to men (50% vs 18%, 
p = 0.05) at 6 months’ post- MTBI (van der Horn, Spikman, Jacobs & van der Naalt, 2013). 
A study by Bay, Sikorskii, & Saint-Arnault, (2009), of 159 outpatients in 
rehabilitation after mild to moderate TBI, found a higher frequency of depressive symptoms 
in women than in men during the first 6-months post-injury (measured by the CES-D).  The 
authors proposed that women were more at risk of depressive symptoms after TBI and cited 
post-injury chronic stress as a major explanatory factor for this as it was measured at a higher 
rate relative to men.  The BIONIC study, (2018), found that across the baseline and 6 month 
timepoints of their 48-month longitudinal study, women produced significantly higher scores 
for anxiety and depression on the HADS scale than men and that at 12- and 48-month follow-
up women’s scores for anxiety were significantly higher than the men’s scores.  Rates at each 
time point were not provided in the study.   
King, (2014) highlighted, from his literature review of 77 studies, four studies which 
reported correlation data on gender and outcome after MTBI.  Post-concussive symptoms in 
general were reviewed which included subjective physical complaints, cognitive, emotional 
and behavioural changes which could be chronic, permanent or late emerging (but not 
specifically depression and anxiety).  Three of the studies reported a positive correlation 
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between female gender and poorer symptomatic outcome relative to males 12-18 months 
post-injury and the smallest study found no correlation.  Scholten et. al., 2016 found that 
females were at higher risk for anxiety and depressive disorders after TBI (1.5 – 5 years post-
injury).  Correlational studies reviewed by King (2014) at 3-6 years post-MTBI, found that in 
two out of the four studies females were at higher risk for ‘permanent’ post-concussive 
symptoms.  One study, found that women had a significantly higher prevalence of anxiety 
than men after 3-5 years post-TBI, but the effect size was small (0.17), (Edna & Cappelen, 
1987). 
The evidence regarding gender differences is mostly based on findings from the 
sports-concussion research which involves measures at the early phase (up to 3 months) after 
MTBI and is to date inconclusive.   Longer-term studies do suggest a higher female 
prevalence and severity of depression and anxiety symptoms post-MTBI but no higher than 
that in the general population.   
Summary and Aims 
Many studies to date that have investigated long-term outcomes of mild TBI have 
used hospital and clinic-based samples which may bias the research towards moderate-severe 
TBIs and exclude cases of MTBI, which approximate 95% of all TBI cases in New Zealand.  
In terms of outcomes from MTBI, very few studies have investigated the gender differences 
in depression and anxiety disorders over time and findings are variable and inconclusive.  
Furthermore, there are limited studies which involve comparisons with the general 
population.  Overall, much of the research presented suggests that depression and anxiety are 
common sequelae of MTBI, particularly in the first year following injury and that these 
symptoms have a detrimental effect on rehabilitation from MTBI.  Additionally, post-
concussion symptom assessment within the first 3-6 months of TBI may mask the 
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identification of the long-term effects and course of depression and anxiety disorders post-
injury and this warrants further analysis of symptoms over time. 
In the acute phase, mean scores for depression have been reported to significantly 
increase in the first 14 days and then to significantly decline to 48 months post-injury, 
although these scores are not in the clinical range.  In some studies the prevalence of 
depression is higher and decreases over time and in others the prevalence is lower and 
increases over time.  Long-term prevalence for depression has been reported as between 9% 
and 43% , on average 1.5 – 6 years post-injury, but studies that have used control or 
comparison groups to test differences in depression levels between post-MTBI and TBI-free 
participants have been limited, particularly longer-term longitudinal studies.   Theadom et. 
al., (2016) proposed that the levels of depression found in the authors’ prevalence studies 
were comparable with the general population.   
Research suggests that anxiety levels increase during the acute phase post-injury, peak 
at 6-months and decrease significantly over 48-months but again are comparable with the 
general population.  Experimental studies using a control or comparison group to test 
differences in anxiety levels between post-MTBI and TBI-free participants have been limited, 
particularly longer-term studies, and have shown mixed results. 
With regard to gender differences, there is some evidence that overall females have 
higher post-MTBI depression and anxiety scores and in general worse outcomes than males 
after MTBI. There is also some evidence suggesting that being female is a predictor of 
depression and anxiety following MTBI.  However, with a lack of control group 
comparisons, there is limited evidence that these findings are not purely a reflection of the 
fact that women experience more depression and anxiety than men in the general population 
(APA, 2013). 
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As Barker-Collo et. al., (2018) concluded, there are multiple trajectories of depression 
and anxiety after MTBI and no studies have yet been done on the gender differences in the 
longer-term trajectory of post-MTBI depression and anxiety disorders after 8-years compared 
with the general population.  In order to guide research and clinical practice with regard to 
effective evidence-based interventions for prevention and treatment of MTBI-related 
depression and anxiety disorders, my study investigated gender differences in the longer-term 
course of depression and anxiety symptoms 8-years following MTBI by conducting a 
longitudinal analysis of symptoms.  This overall aim was two-fold: the first was to identify 
gender differences in the recovery trajectory of depression and anxiety over 1-month, 12-
month and 8-year timepoints post-injury.  The second was to investigate the gender 
differences in depression and anxiety scores between a group of MTBI subjects (8-years post-
injury) and a group of participants who were TBI-free by comparing Hospital Anxiety and 






Participants for the MTBI group were initially recruited via the Brain Injury Incidence 
and Outcomes New Zealand in the Community (BIONIC) study. This was a large population-
based epidemiological study carried out between 2010-11 that examined the incidence and 
outcomes (up to 12-months) of TBI across all age groups (Feigin et al., 2013).  The aim of 
the current Brain Injury Outcomes New Zealand In The Community 8-years Later 
(BIONIC8) study was to explore outcomes of MTBI at 8-years post-injury and this thesis 
focuses on gender differences in depression and anxiety over time following a MTBI, using 
the Hospital Anxiety and Depression Scale.  The first objective was to identify gender 
differences in the recovery trajectory of depression and anxiety over 1-month, 12-month and 
8-year timepoints post-injury.  The second was to investigate the gender differences in 
depression and anxiety scores between a group of MTBI subjects (8-years post-injury) and a 
group of participants who were TBI-free by comparing Hospital Anxiety and Depression 
Scale (HADS) scores and self-reported symptoms.  
The definition of TBI used by the BIONIC studies was based on the World Health 
Organisation (WHO) definition of “an acute brain injury resulting from mechanical energy to 
the head from external physical forces” (Carroll et. al., 2004, p. 115) and not due to drugs, 
alcohol, medications, other injuries or treatment for other injuries, or other problems, such as 
psychological trauma. To meet the requirements for having sustained a TBI, as well as 
evidence of a TBI as defined by WHO, the participant also had to report at least one of the 
following symptoms following their head injury: 1) dazed, confused or had ‘seen stars’ at the 
time of injury; 2) loss of consciousness; 3) post-traumatic amnesia or any post-injury memory 
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loss; or 4) other neurological abnormalities such as focal neurological signs, seizure and/or 
intracranial lesions. 
The TBI severity for each participant’s primary injury was classified according to the 
Glasgow Coma Scale (GCS) which assesses the level of consciousness of patients with an 
acute brain injury, with the scores as follows: mild (GCS score of 13-15 and Post Traumatic 
Amnesia (PTA) of less than 24 hours), moderate (GCS score of 9-12 and 1-6 days of PTA) or 
severe (GCS score of 3-8 and 7 or more days of PTA) (Teasdale & Jennett, 1974). Scores for 
the GCS were recorded from medical records where available.  Where participants did not 
have a GCS or PTA score recorded in their medical notes their TBI was classified as mild 
(GCS score of 15), as moderate or severe TBI’s would have necessitated immediate medical 
assistance by the ambulance service or a primary or secondary health care service where GCS 
is routinely recorded. 
Participants were recruited for the BIONIC study if they had experienced a TBI 
between the period of March 1st, 2010 and February 28th, 2011. Inclusion criteria involved 
living in Hamilton City (urban), or in the Waikato District (rural), of New Zealand. This 
geographical area was selected for the study as the demographic and social characteristics of 
this population reflected the overall population of New Zealand (Statistics New Zealand, 
2006). Participants were also required to have lived within this designated area for at least 12-
months prior to their head injury. No other exclusion criteria were employed for the TBI 
group.  Those participants that consented to be part of the original BIONIC study were 
followed up with in-person assessments over the 12-months following their TBI and then at 
4-years post-injury to assess the longer-term impacts of TBI via an extended Health Research 
Council (HRC) funded study called BIONIC4you (Brain Injury Outcomes New Zealand in 
the Community: 4 Year Outcomes).  Further details of the methodology used in the original 
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BIONIC study and BIONIC4you study can be found in Theadom et al., (2012) and Barker-
Collo et al., (2018) respectively and in Feigin et al., (2013). 
During the 12-month and 4-year post-injury assessment participants were asked for 
their permission to be contacted regarding any related future studies including this current 
study known as the Brain Injury Outcomes New Zealand In The Community 8-years Later 
(BIONIC8) study, funded by Waikato Medical Research Foundation.  This study was an 
extension of the BIONIC and BIONIC4you studies, and investigated the outcomes of TBI on 
adults (aged 16 and over) at 8-years post-injury compared with an age and gender matched 
comparison group.  The purpose of this study was to characterise the most persistent 
difficulties experienced by participants after their TBI, to identify those at high risk of poor 
long-term outcomes and to identify the factors that influence recovery.  My particular 
research focused on the pattern of recovery after MTBI in relation to depression and anxiety 
and associated gender differences. 
The BIONIC8 study was co-ordinated by the School of Psychology, University of 
Waikato, Hamilton, New Zealand, in collaboration with the National Institute for Stroke and 
Applied neurosciences at AUT University, Auckland.  The study received approval from the 
Southern Health and Disability Ethics Committee (17/STH/247/AM01). 
Participants  
TBI group.  
Participants of the BIONIC and BIONIC4You studies, currently aged 16 years and 
over, who had given permission to be contacted (n=467) were invited to complete a study 
questionnaire.  The recruitment of participants from the BIONIC study into the current study 




Of the 467 participants invited, 228 consented to participate in the current study and 
the final sample consisted of 151 people, with an equal proportion of genders:  77 males 
(51%) and 74 females (49%).  In terms of ethnicity, there were 115 European (76.2%), and 
30 Māori (19.9%) participants.  Nearly 60% of participants had experienced multiple TBI 
(two or more injuries), and over 33% of these people had experienced four or more injuries in 
8-years.  The remainder of participants (40.4%) had sustained only one TBI at the eight year 
assessment.  Most injuries were caused by falls (32.5%) followed by traffic/motor vehicle 
accidents (25.8%).  Characteristics of the MTBI group who completed the 8 year assessment 





MTBI group characteristics 
 Male (%) Female (%) Total n (%) 
    
 77 (51) 74 (49) 151 
Age at eight year assessment M (SD)  
Age range 24-90 
43.2 (16.1) 47.7 (17.8) 45.4 (17.1) 
 
Mechanism of injury, n (%)    
Fall 21 (27.3) 28 (37.8) 49 (32.5) 
Traffic/motor vehicle accident 23 (29.9) 16 (21.6) 39 (25.8) 
Exposure to mechanical force 15 (19.5) 15 (20.3) 30 (19.9) 
 Assault 17 (22.1) 13 (17.6) 30 (19.9) 
 Unknown   0   1 (1.4)   1 (0.7) 
Number of TBI at eight year 
assessment, n (%) 
   
 One 24 (31.2) 37 (50) 61 (40.4) 
 Two 23 (29.9) 18 (24.3) 41 (27.2) 
 Three 9 (11.7)  6 (8.1) 15 (9.9) 
 Four or more 18 (23.4) 12 (16.2) 30 (19.9) 




















Comparison group.  
Comparison participants were recruited to match the age and gender of the TBI 
participants at their 8-year post-injury assessment.  Participants were required to be aged 16 
or over and TBI-free over their lifetime.   
Participants for the comparison group were recruited via local advertisement through 
posters and social media and contacted the study by email if they were interested in taking 
part.  Comparison group participants were also recruited via ResearchNow  (a company 
hosting a New Zealand based panel of participants) as this method proved feasible in the 
BIONIC4You study.  A study information sheet describing the study was emailed to potential 
participants.  Exclusion criteria for the comparison group included any participant that had 
previously experienced a TBI in their lifetime.  A series of exclusion questions were asked 
based on the Ohio State University TBI Identification Method (Corrigan & Bogner, 2007), 
which was used as an eligibility screen.  Participants were asked five probe questions, such as 
‘have you ever injured your head or neck in a fall or from being hit by something (for 
example falling from a bike or horse, rollerblading, falling on ice, being hit by a rock), or by 
playing sports or on the playground.’ Each positive response was followed by two additional 
questions: ‘did you lose consciousness’ and ‘did you feel dazed or have a gap in your 
memory’. If participants in the Comparison group indicated loss of consciousness or feeling 
dazed or confused after any incident, they were deemed ineligible and did not complete the 
study specific questionnaire. 
Sample Characteristics. 
The demographic characteristics of the TBI and Comparison groups are summarised 
in Table 2.  The two groups were compared across four variables using a chi square for 
frequency counts and a t-test (or non-parametric equivalent). There were no significant 
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differences between the MTBI and Comparison group for age or gender.  The age of those in 
the MTBI group ranged from 24-90 years, with a range of 24-71 years for the Comparison 
group.  There was a significant difference in ethnicity between groups; both MTBI and 
Comparison groups were predominantly European (76.2% and 63.8%, respectively).  The 
difference in ethnicity between the groups is due to the greater proportion of those in the 
Comparison group self- identifying as other ethnicities (31.9s%); additionally, Māori were 
less represented in the Comparison group (4.3%) than the MTBI group (19.9%). 
As an indication of socioeconomic stats (SES), the occupation of the participant at the 
time of assessment was coded into major groups from Australian and New Zealand Standard 
Classification of Occupations (ANZSCO); professional (including managerial/technical), 
skilled (including non-manual, skilled manual, partly skilled) and other (including armed 
forces, unemployed/retired/student).  Pearson’s chi-squared test revealed no significant 
association between groups (MTBI or control) and ANZSCO group, suggesting the two 










  c2 or t 





45 (15.2)                          
 
t(360) = .286, p = .775 
Male gender n (%) 77 (51.0) 104 (49.2) c2(1) = .102, p = .749 
Classified Ethnicity, n (%) 
        European 
        Māori 
        Other 
 
115 (76.2) 
 30 (19.9) 
   6 (4.0) 
 
134 (63.8) 
    9 (4.3) 
 67 (31.9) 
c2(2) = 55.572, p = .000 
ANZSCO major group n (%) 
         Professional 
         Skilled 






 77 (36.5) 
40 (19.0) 
94 (44.5) 
c2(2) = .710, p = .701 
    
Materials and Standardised Measures    
Participants completed a questionnaire about their current health, including 
subsequent TBIs and hospitalisations since their initial assessment.  They were asked about 
any psychological or mood disturbance (Hospital Anxiety and Depression Scale – HADS and 
Post-traumatic Stress Disorder Checklist – PCL-C),  cognitive functioning (Cognitive 
Complaint After Closed Head Injury – CCACHI), post-concussive symptoms (Rivermead 
Post Concussion Symptoms Questionnaire – RPQ), living and work arrangements, work 
limitations, substance use, current medications and community participation (The 
 44 
Participation Assessment with Recombined Tools – Objective – Part O).  The questionnaire 
utilised a set of standardised measures and a study-specific subset of the questionnaire 
assessments retained from the BIONIC and BIONIC4you studies to enable observation of 
recovery trajectories following injury after 8-years.  To maximise participation, 
questionnaires could be completed online, via the Qualtrics platform, or during a face-to-face 
interview at the participant’s home or other suitable location.  The measures I used in my 
thesis are described below.   
Study specific questionnaire. 
Demographic and background information.   
Participants were asked to report their age, gender, ethnicity, occupation of the main 
income earner in the household, living and financial situation, educational attainment, 
employment, their marital status and ethnicity.  
TBI participants were also asked to report all hospital admissions during the study 
period (8-years), whether or not these were related to the TBI.  The Ohio State University 
TBI Identification Method (Corrigan & Bogner, 2007) was used to identify recurrent TBI in 
the TBI group and as an eligibility screen for the comparison group.  
Ethnicity.  
Each participant was provided with a list of different ethnicities from which they were 
asked to select one or more as appropriate.  In line with the initial BIONIC study 
methodology (Feigin et al., 2013), in instances where several ethnicities were chosen a 
prioritisation system was used to obtain a single ethnicity and priority was given to Māori, 
Pacific peoples, Asian, Middle Eastern/Latin American/African, Other ethnicity and 
European.  Standard procedures described by the Ministry of Health’s Ethnicity Data 
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Protocols were used.  These protocols are consistent with Statistics New Zealand’s Statistical 
Standard for Ethnicity and identify the minimum standards that apply across the health and 
disability sector (Ministry of Health, 2017). 
 For the current study, participants were classified as European, Māori, or other. The 
category of ‘other’ was a heterogeneous group, with all other ethnicities aggregated due to 
the small number of individuals in the remaining ethnic categories. 
Recurrent TBI.  
The study questionnaire asked TBI group participants to recall any subsequent TBIs, 
and, to be consistent with the original BIONIC studies, TBI was defined using the WHO TBI 
definition criteria of  “an acute brain injury resulting from mechanical energy to the head 
from external physical forces” (Carroll et al., 2004).  Operational criteria for recurrent TBI 
included the presence of one or more of the following: (1) confusion or disorientation; (2) 
loss of consciousness; (3) post-traumatic amnesia; (4) other neurological abnormalities (e.g., 
seizure) as a result of an injury to the head.  TBI recall was facilitated by the Ohio State 
University Traumatic Brain Injury Identification Method – OSU-TBI-ID (Corrigan & 
Bogner, 2007) which used eligibility screening questions designed to facilitate recollection of 
injuries or events that could result in a TBI or concussion, and has demonstrated predictive 
validity and reliability in self-report recall of lifetime TBI (Gardner, Langa, & Yaffe, 2017). 
Participants were asked five probe questions, such as ‘have you ever injured your head or 
neck in a fall or from being hit by something (for example falling from a bike or horse, 
rollerblading, falling on ice, being hit by a rock), or by playing sports or on the playground.’ 
Each positive response was followed by two additional questions: ‘did you lose 
consciousness’ and ‘did you feel dazed or have a gap in your memory’. This information was 
used to determine the number of recurrent injuries in the MTBI group and positive responses 
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were followed up with a phone interview by a member of the research team to collect further 
information about each incident, including the date and cause of injury.  
A more detailed description of the psychological and mood disturbance measure used 
in this thesis, the Hospital Anxiety and Depression Scale, is provided below: 
Hospital Anxiety and Depression Scale (HADS). 
The Hospital Anxiety and Depression Scale (HADS) was completed by participants to 
assess their levels of depression and anxiety. The HADS is a brief  (2-5 minute) 14 item self-
report questionnaire, developed by Zigmond and Snaith (1983) to examine levels of 
depression and anxiety in non-psychiatric populations. It consists of an Anxiety subscale and 
a Depression subscale, with seven items related to each subscale (see Appendix A).  
The Anxiety subscale assesses the participant’s worries and fears with statements 
such as “I get sudden feelings of panic” and “I can sit at ease and feel relaxed”. The 
depression subscale predominantly examines the participant’s ability to feel pleasure 
(anhedonia) with statements such as “I look forward with enjoyment to things” and “I have 
lost interest in my appearance.” Both the HADS Depression and Anxiety subscales were used 
in this current study, as an indication of the current mental health status of the participants. 
The HADS responses are on a 4-point Likert scale, and scores range from 0 to 3 for 
each question. Respondents are asked to select the response that best described the extent to 
which each symptom had applied to them  over the previous week, (for example, ‘yes, 
definitely’, ‘yes, sometimes’, ‘no, not very much’ and ‘no, not at all’). The minimum score 
for each subscale is 0 and the maximum score is 21. Higher scores on both subtests suggest 
greater difficulty with symptoms of depression or anxiety.  In the current study a cut-off of 11 
for each subscale was used, as a score above 11 on either subscale is considered to indicate a 
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moderate to high presence of that particular mood disorder (Snaith, 2003).  A score between 
0 -7 on either subscale is considered to be within the normal range, while a score of 8 - 10 
indicates the possibility of the respective mood disorder.  The HADS has been widely used 
with TBI populations (Anson & Ponsford, 2006, Hawley, 2003) and is considered to perform 
well in screening for the presence of depression and anxiety disorders within the general 
population, (Bjelland, Dahl, Haug, & Neckelmann, 2002).  The HADS has high internal 
consistency and sensitivity to change with good concurrent validity and correlations between 
the HADS and other commonly used questionnaires for depression and anxiety ranging from 
0.60 and 0.80 (such as the State-Trait Anxiety Inventory, Beck Depression Inventory and the 
Symptom Checklist 90 Scale (Bjelland et al., 2002).   
The responses to the individual items of the measure as well as total scores for anxiety 
and depression were used in the analyses.   
Procedure 
TBI group.  
Contact information for TBI group participants (aged 16 or over and who had given 
permission to be contacted regarding future studies) was extracted from the BIONIC and 
BIONIC4you study databases.  I was one of three Research Assistants collecting participant 
data for the BIONIC8 study and participants were contacted by telephone to assess their 
interest in the current study.  I was assigned to contact 153 participants in total.  A Patient 
Consent Form and Information Sheet was posted, emailed or faxed to those who expressed an 
interest (Appendix B).  If willing to take part, participants were asked to print, sign, scan and 
email (or post/fax) their written consent form back to the research assistant or to provide 
verbal consent over the telephone (which was recorded).   During the study we received 
approval to obtain consent online, and this method was used if preferred by the participant.  
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In these cases, a link to the online consent was emailed to the participant and once completed 
consents were submitted online direct to the Research Assistant.   Once informed consent was 
obtained, participants were emailed a link to complete the study assessment questionnaire 
online (via the Qualtrics platform), or if preferred, a time was arranged to complete the 
assessment face-to-face at the participant’s home or other suitable location.  Participants were 
invited to ask questions about the study at any stage of the recruitment process.  The timeline 
for contact to be made with the participant and for submission of the completed study 
questionnaire was within two months either side of the participant’s initial TBI anniversary 
date. 
If a participant could not be contacted, the researcher attempted to telephone at 
different times and days and contacted any alternative contact numbers available for the 
participant.  If contact was still unable to be made, a letter (contact slip) was sent to the 
address provided asking the participant to contact the BIONIC8 team.  If there was no 
response from this letter, the researcher checked the New Zealand telephone directory (White 
Pages) for listings that met the participant’s criteria.  Any potential listings were contacted 
and asked if they knew the participant in question.  If this failed to locate the participant, the 
electoral roll was checked for that participant and contact slips were sent to all addresses 
found featuring the participant’s name.  If no listing met the participant’s criteria from the 
electoral roll, the GP was contacted (if GP details were known).  Finally, if this failed to 
enable contact with the participant, the participant’s NHI number was checked for contact 
details by a research assistant based at the local hospital (Waikato).    If contact was not made 
within two months of the anniversary date of the initial TBI, the participant was deemed to be 
un-contactable and further attempts to locate them ceased.  
On completion of the questionnaire, participants were contacted again if they had 
indicated that they had experienced a recurrent head injury since the primary injury in 
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2010/11, or if they had been hospitalised at all during that time.  Participants who scored in 
the abnormal range (>11) for the Hospital Anxiety and Depression Scale (HADS) were also 
contacted, informed and encouraged to seek medical advice.  If they consented, this 
information was also passed to their General Practitioner for follow-up. 
Comparison group.  
Participants for the comparison group, recruited via advertising or through 
ResearchNow, were provided with a study information sheet via email and a link to the 
online consent form and questionnaire.   
On completion of the questionnaire assessment, the TBI group participants received a 
$10 Warehouse store voucher as a ‘thank-you’ compensation.  The comparison group 
participants recruited via ResearchNow were reimbursed at the standard rate of $7.50 for a 
completed questionnaire. 
Statistical Analysis  
Quantitative data analyses were undertaken using SPSS (version 25).  There were no 
extreme outliers as identified by boxplot; however, a z-score analysis (standard deviations 
from the mean of > +3.29) identified 6 outliers in total, one of which was an outlier on two 
variables.   These outliers were excluded from the analyses.   
The first stage of data analysis examined the prevalence of depression and anxiety 
symptoms by gender within the TBI sample at each post-injury assessment (at 1-month, 12-
months using existing data and 8-years).  This included examining the total HADS scores for 
anxiety and depression subscales and identifying those scores that met the current study 
clinical cut-off score for depression and anxiety (>11).  Within-subject repeated measures 
two-way ANOVA and post-hoc tests were conducted to determine if there were significant 
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changes in depression and anxiety mean scores over time in males and females for the MTBI 
group.  To test for an association between gender and a score exceeding the clinical cut-off 
score for depression and anxiety across time, a chi-squared test was carried out with Fisher’s 
Exact test reported as cell sizes were small.  For each of these tests, only individuals with 
data on the scale of interest at all assessment points were included.    
The second stage of data analysis involved evaluating between-group differences for 
depression and anxiety symptoms after 8-years by gender and this was examined using 
parametric tests (2 x 2 between group ANOVA) and non-parametric techniques (chi-squared 
test) when the data was categorical.  Effect sizes were calculated using Cohen’s ‘d’ for 
continuous variables where .2 is a small effect size, .5 medium and .8 large (Cohen, 1988).  
Results were summarised using means (95% confidence intervals [CI]) and standard 
deviations.   
Bonferroni correction was used to account for the multiplicity of tests of a given 




The results are presented in two parts.  Firstly, recovery trajectories and clinical ( or 
abnormal) ratings of depression and anxiety symptomology (based on the HADS 
measurement tool) were examined in males and females at 1-month, 12-months and 8-years 
post-MTBI (Aim 1).  Secondly, gender differences in depression and anxiety outcomes for 
adults eight years after experiencing MTBI were investigated and compared to the TBI-free 
group (Aim 2).  For each section, depression symptoms are considered first, followed by 
anxiety symptoms. 
Recovery Trajectories in Males and Females post-MTBI (Aim1) 
Depression.  
 In order to track changes in depression scores over time, the first stage of the data 
analysis examined the total score of depression symptoms by gender within the TBI sample at 
each assessment (at 1-month, 12-months and 8-year follow-up).   
Figure 2 shows that the pattern of scores in men and women was similar over time 
and that the females had higher scores at each time point.  For both men and women the 
depression scores decreased at a similar rate between 1-month and 12-months post-injury.  
These scores then increased, again at a similar rate, between 12-months and 8-years. The 
mean scores at each time point were within the normal range (< 8) and below the cut-off 
score for clinically significant symptoms (>11).    
The sample for repeated measures analysis consisted of 90 people (48 male, 42 
female) as all other participants had missing data at one or more time points.   
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A repeated-measure two-way ANOVA was conducted to examine the changes in 
depression scores over time in males and females. The interaction between time and gender 
was not statistically significant F(2,176) = .823,  p = .441, h2 = .009.   
The main effect of time, however, showed that there was a statistically significant 
difference in depression scores across time points, F(2, 176) = 5.487, p = .005, partial h2 
= .059.  Bonferroni corrected post-hoc test revealed that the increase in scores between 12-
months and 8-years was statistically significant (p = .002).  The decrease in scores between 1-
month and 12-months was not statistically significant (p = .054) and neither was the change 
in scores between 1-month and 8-years (p = 1.000).   
The main effect of gender showed a statistically significant difference in mean 
depression scores between males and females, F(1,88) = 4.050 p = .047, partial h2 = .044 
with females having the highest scores. 
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Figure 2. Mean HADS Depression Scores over time by gender 
Anxiety.   
In order to track changes in anxiety scores over time, examination of the prevalence 
of anxiety symptoms by gender within the TBI sample at each assessment (at 1-month, 12-
months and 8-year follow-up) showed that the scores for both genders followed the same 
pattern across the three time points (Figure 3).  The females had higher scores at each time 
point.  For both men and women the anxiety scores decreased from 1-month, where the 
gender difference was least pronounced, to 12-months post-injury, and with a slightly greater 
rate of decline in scores for men.  The gender difference was most pronounced at 12-months, 
at which point anxiety scores stabilised up to the 8 year point for both genders with a slight 
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decline for women’s scores at the 8 year point.  The mean scores at each time point, which 
were higher overall than the mean scores for depression, were within the normal range (< 8) 
and below the cut-off score for clinically significant symptoms (>11).    
Figure 3. Mean HADS Anxiety Scores over time by gender 
The sample for repeated measures analysis consisted of 89 people (47 male and 42 
female) as all other participants had missing data at one or more time points. A two-way 
repeated measure ANOVA was conducted to examine changes in anxiety scores over time in 
males and females.  The interaction between time and gender was not statistically significant, 
F(2,174) = .447, p = .640, h2 = .005.   
The main effect of time, however, showed a statistically significant change in mean 
anxiety scores across the three time points, F(2, 174) = 6.280, p = .002, partial h2 = .067.  
Bonferroni corrected post-hoc tests found that the decrease in mean anxiety scores between 
1-month and 12-month and between 1-month and 8-years’ post-injury was statistically 
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significant (p = .022 and p = .006, respectively).  The very slight decrease in anxiety scores 
between the 12-month and 8 year point was not statistically significant (p = 1.000). 
The main effect of gender showed that there was a statistically significant difference 
in mean anxiety scores between males and females F(1,87) = 6.948, p = .010, partial h2 
= .074 with females having the highest anxiety scores. 
Clinical Range Scores. 
Mean score analysis can mask the number of people who have scores within the 
clinical range for depression and anxiety which indicates a higher degree of symptom-
reporting. Therefore, to ascertain the number of people whose scores met the clinical cut-off 
for depression and anxiety across time, the frequencies, and then association with gender, 
were explored. 
The number of participants exceeding the clinical cut-off score for depression (>11 on 
the HADS) at each of the three assessment periods was calculated.  Figure 4 shows that the 
percentage of total TBI participants that exceeded the clinical cut-off score for HADS 
depression (>11) was greatest at the one month and 8 year assessment points (5.8% and 6.1% 
respectively).  The percentage of TBI group males and females exceeding cut-off score at one 
month was equal (2.9%) and at 12-months and 8-years there was a greater percentage of 
females exceeding cut-off score for depression (2.5% of females vs 0.8% of males and 4.1% 
of females vs 2% of males, respectively).  The 8 year point saw the highest percentage of 
females exceeding cut-off score and the percentage of men exceeding cut-off score was 
highest at the one-month point.  The lowest percentage of both males and females exceeding 
cut-off score was at the 12-month point.  
 56 
 
Figure 4. Percentage of TBI group with scores in the clinical range for HADS depression 
over time by gender. 
To determine if the same people exceeded cut-off score across timepoints, all 
participant scores were reviewed.   An analysis of TBI participants’ depression scores over 
time showed that 11% of participants (10 out of a total of 90) had one or two reports of a 
clinical score for depression across the 8 year assessment timeframe.  Eight participants had 
one report (four of these were reported at 1-month, two cases at 12-months and two cases at 
8-years) and two participants (20% of those reporting a clinical score) had two reports of 
clinical scores for depression (two cases at 1-month, one case at 12-months and one case at 8-
years).  No participants reported depression scores above the clinical cut-off at all three 
timepoints. 
To test for an association between gender and exceeding the clinical cut-off score for 
depression at the one month, 12-month and 8-year assessment dates, a chi-squared test was 
carried out with Fisher’s Exact test reported, given the small cell sizes.   There was no 
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depression over time: one month, χ2(1) = .059,  p = 1.000; 12-months, χ2(1) = 1.069, p = .365 
or 8-years, χ2(1) =  1.245, p = .318.  
The number of participants exceeding the clinical cut-off for anxiety (>11 on the 
HADS) at each of the three assessment periods was identified.  Figure 5 shows that the 
percentage of total participants exceeding HADS anxiety clinical cut-off scores was greatest 
at the one month (6.73% female, 3.85% male) and 12-month assessment points (6.61% 
female, 0.83% male) and at 8-years the proportion was 4.11% female and 1.37% male.  At 
each time point, there was a greater percentage of females than males exceeding the cut-off 
score.  The percentage of males was highest at one month post-TBI,  lowest at 12-months and 
increased slightly at 8-years.  The percentage of females was greatest at one month and then 
declined at both 12-months and, more substantially, at 8-years.   
 
Figure 5. Percentage of TBI group with scores in the clinical range for HADS anxiety over 
time by gender. 
An analysis of TBI participants’ anxiety scores over time showed that over 15% of 
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anxiety across the 8 year assessment timeframe.  Ten participants had just one report (eight 
cases at 1-month, one at 12-months and one at 8-years) and four participants (29% of those 
reporting a clinical score) had two reports of anxiety scores within the clinical range up to the 
8 year assessment point (three cases at 1-month, three cases at 12-months and two cases at 8-
years).  No participants had scores in the clinical range for anxiety across all three timepoints.  
To test for an association between gender and a score which exceeded the clinical cut-
off score for anxiety at the one month, 12-month and 8 year assessment dates, a chi-squared 
test was conducted with Fisher’s Exact test reported, given the small cell sizes.    
 There was no statistically significant association between gender and the proportion 
of participants exceeding the clinical cut-off for anxiety at the one month or 8-year 
assessment points,  χ2(1) = 1.689, p = .217 and χ2(1) = 2.356, p = .158 but there was a 
statistically significant association between gender and proportion exceeding the clinical cut-
off at 12-months, χ2(1) = 6.008, p = .017, φ = .223, p = .014, with a much higher proportion 
of females reporting scores within the clinical range for anxiety.  
Co-morbid depression and anxiety. 
At the 1-month assessment, four participants had a score in the clinical range for both 
depression and anxiety; at the 12-month assessment, one participant had a score in the 
clinical range for both and at the 8 year assessment, two participants had a score in the 
clinical range for both. 
Summary 
There was a statistically significant increase in depression scores from 12-months to 
8-years and a statistically significant decrease in scores for anxiety from 1- to 12-months and 
from 1-month to 8-years.  Females scored significantly higher than males for both depression 
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and anxiety overall. There were no significant gender differences in the changes in mean 
HADS scores for depression or anxiety over time.  
The number of people whose scores exceeded the clinical cut-off  score (>11) for 
depression and anxiety across time followed the same pattern as the mean scores for males 
and females.  Females generally had a much higher percentage of scores in the clinical range 
for depression and anxiety.  There was no significant association between gender and the 
percentage of participants who exceeded the clinical cut-off score, except for anxiety at the 
12-month point, with a much higher percentage of females scoring in the clinical range.  
However, the strength of this association was low.  Most cases which exceeded the clinical 
cut-off scores for depression or anxiety were single cases over the whole assessment period 
and no participants reported a clinical range score at each assessment timepoint. 
Gender Differences in HADS Scores for Depression and Anxiety between 
MTBI and Comparison Groups (Aim 2) 
Depression.  Figure 6 shows that, overall, the TBI group had higher scores for 
depression than the comparison group at the 8 year post-injury point.  Males in the TBI group 
had higher depression scores than males in the comparison group.  Females in the TBI group 
had higher depression scores than females in the comparison group.  In both groups, females 
had higher depression scores than males overall.  
A 2 x 2 between-group ANOVA was carried out to analyse the differences in HADS 
depression scores at 8 yrs post-injury, by group (TBI and Comparison) and gender.   
There was no statistically significant interaction between the group membership and 
gender on the HADS scores for depression F(1,352) = .059, p = .809, h2 = .003.  There was 
no statistically significant main effect of gender on the HADS score for depression, F(1,352) 
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= 2.010, p = .157, h2=.001 nor was there a  statistically significant main effect of group on 
the HADS score for depression, F(1,352) = 3.306, p = .070, h2=.005.   
 
 
Figure 6. Graph of the interaction of gender and group for HADS Depression Scores 
Anxiety.   
Figure 7 shows that, overall, the comparison group had higher scores for anxiety than 
the TBI group at the 8 year post-injury point.  Males in the comparison group had higher 
anxiety scores than males in the TBI group.  Females in the TBI group had slightly higher 
anxiety scores than females in the comparison group.  In both groups, females had higher 
anxiety scores than males overall.  
A 2 x 2 between-group ANOVA was carried out to analyse the differences in anxiety 
scores at 8 yrs post-injury, by group (TBI and Comparison) and gender.  
There was no statistically significant interaction between the group membership and 
gender on the HADS scores for anxiety F(1,350) = .505, p = .478, h2=.001, nor a significant 
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main effect of group , F(1,350) = .089, p = .766, h2=.000.  There was, however, a statistically 
significant main effect of gender for the HADS score for anxiety after 8-years, F(1,350) = 
8.725, p = .003, h2=.024 showing a statistically significant difference in anxiety scores 
between genders.  In both groups, females had higher anxiety scores than males overall.  
 
Figure 7. Graph of the interaction of gender and group for HADS Anxiety Score 
Clinical Range Scores. 
To investigate relationships between group (MTBI or Comparison), gender and 
clinical range HADS scores for anxiety and depression, participants who exceeded the 
clinical cut-off score for depression or anxiety (>11) were identified.    
As shown in figure 8, the percentage of the comparison group with HADS depression 
scores in the clinical range was lower than that of the MTBI group overall with a much 
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greater proportion of females than males, in both groups, with scores in the clinical range at 
assessment. 
 
Figure 8. The percentage of TBI and comparison group with scores in the clinical range for 
depression, by gender 
As shown by Figure 8, within the MTBI group, 6% of participants had scores within 
the clinical range for depression at 8-years, compared to 2.9% of the comparison group.   
A chi-squared test for association was conducted between group and scores within the 
clinical range for depression.   All expected cell frequencies were greater than five. There 
was no statistically significant association between group and scores within the clinical range 
for depression, χ2(1) = 2.119, p = .145.  The same test was used to identify associations 
between gender and scores within the clinical range for depression. There was no statistically 
significant association between gender and scores within the clinical range for depression, 
χ2(1) = 3.249, p = .071.    
As shown in figure 9, the percentage of the comparison group with HADS anxiety 
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less overall.  The comparison group had a greater proportion of females than males with 
scores in the clinical range at assessment as did the MTBI group. 
 
Figure 9. The percentage of TBI and comparison group with scores in the clinical range for 
anxiety, by gender 
As shown by figure 9, within the MBTI group, 5.4% of participants had scores in the 
clinical range for anxiety, compared to 5.3% of the comparison group.   
A chi-square test for association was conducted between group and scores in the 
clinical range for anxiety.   All expected cell frequencies were greater than five. There was no 
statistically significant association between group and scores in the clinical range for anxiety, 
χ2(1) = .003, p = .958.  The same test was used to identify associations between gender and 
scores in the clinical range for anxiety.   All expected cell frequencies were greater than five. 
There was no statistically significant association between gender and scores in the clinical 
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Group and Gender Differences in Symptom Reporting at HADS Item Level 
The current analysis has focused on total HADS scores for both depression and 
anxiety subscales.  To determine whether different depression and anxiety symptoms were 
endorsed by each group and by which gender, analysis of the number of endorsements for 
each symptom of at least moderate severity, was carried out on the 8-year assessment data.   
Figure 10 depicts the percentage of participants in each group (8-years post-MTBI 
and comparison group), by gender endorsing each depression symptom, to at least a moderate 
severity.  The most notable gender differences were in relation to items “I still enjoy the 
things I used to enjoy” with almost twice the number of males in the MTBI group reporting 
moderate to severe symptoms than males in the comparison group.  With the item “ I feel as 
if I am slowed down” both groups had a much higher proportion of females than males who 
indicated moderate to severe symptoms and the MTBI group had the highest proportion 
overall and there were twice as many females than males reporting moderate-severe 
symptoms for this item in the comparison group (22 females vs.11 males).  The MTBI group 
had almost twice the number of people, and more than twice the number of males, scoring in 
the moderate to severe range for the item “I look forward with enjoyment to things” than in 
the comparison group.  The number of participants scoring depression items to a moderate-
severe level are displayed in Table C1 in the Appendix C.  
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Figure 10.  The percentage of TBI and comparison group endorsing moderate to severe 
depression items, by gender  
Mean scores for questions on the HADS depression subscale by group and 
gender– 8 year assessment. 
Figure 11 shows the mean scores of depression subscale items endorsed by TBI and 
comparison groups, by gender.  The majority of depression items followed the same pattern 
of scores with the TBI group having higher mean scores for each item than the comparison 
group (the exception was the item “I have lost interest in my appearance” which was scored 
slightly higher by the comparison group, especially by males).  Females had higher scores 
than males in both groups for most items, except for the items  “I still enjoy the things that I 
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scored slightly higher than females in the MTBI group and higher than the males in the 
comparison group.   
 
 
Figure 11. Mean scores of depression subscale items endorsed by TBI and comparison 
groups, by gender.  
A 2 x 2 between-group univariate analysis (ANOVA) was carried out to analyse the 
gender and group differences in mean scores between the 8-year post-TBI and comparison 
groups for each depression subscale item.  A summary of the results can be found in Table  3 
for depression and Table 4 for anxiety.  The F-values are included in Appendix D.  There was 
no statistically significant group/gender interaction for depression item mean scores.  There 
were no main effects for scores on items “I can laugh and see the funny side of things”, “I 
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There was a significant main effect of group on the items “I still enjoy the things I used to 
enjoy”, F(1,352) = 6.355, p = .012, h2 =.018, “I look forward with enjoyment to things”, 
F(1,352) = 4.451, p = .036, h2 =.012, and on the item “I can enjoy a good book or radio or 
TV program”, F(1,352) = 5.797, p = .017, h2 =.016, with significantly higher scores on these 
items from the TBI group.  There was a significant main effect of gender on the item “I feel 
as if I am slowed down”, F(1,352) = 5.295, p = .022, h2 =.015, with significantly higher 
scores on this item from females in both groups. 
Table 3 










































Enjoy things I used 
to 
.68 .852 .67 .783 .42 .654 .52 .769   Ö  
Laugh/see funny 
side 
.33 .681 .45 .646 .27 .617 .31 .650    
I feel cheerful .43 .596 .55 .602 .43 .671 .49 .635    
Feel slowed down .80 .880 1.07 .839 .77 .694 .90 .788   Ö 
Lost interest in 
appearance 
.49 .872 .68 .864 .68 .863 .70 .838    
 Look 
forward/enjoyment 
.59 .867 .62 .793 .39 .665 .48 .718  Ö  
Enjoy good 
book/TV 
.51 .757 .42 .725 .29 .608 .30 .633  Ö  
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Figure 12 depicts the percentage of participants reporting moderate or severe anxiety 
symptoms 8-years after mTBI, expressed as percentages of the group, by gender. A similar 
pattern is followed by both genders in the MTBI and comparison groups.  In the MTBI group 
the item “sudden panic” shows a much higher frequency of females reporting this symptom 
than males, compared to the comparison group.  Predominantly more females than males 
report moderate to severe symptoms overall in both groups and the pattern of frequency is 
similar to that of the mean scores except for “sit at ease/relax” and “butterflies” which have a 
low frequency of scores from males compared to females but the mean scores are more 
comparable between males and females in both groups.  The number of participants scoring 
anxiety items to a moderate-severe level are displayed in Table C2 in Appendix C. 
 
Figure 12. The percentage of TBI and comparison group endorsing moderate to severe 
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Mean scores for questions on the HADS anxiety subscale by group and gender– 8 
year assessment. 
As can be seen in figure 13, most of the total mean scores for items on the HADS 
anxiety subscale were higher in the comparison group than the MTBI group except for three 
items – “I can sit at ease and feel relaxed”, “ I feel restless as if I have to be on the move” and 
“sudden panic”.  For all items, females scored higher than males in both groups.   
 
Figure 13. Mean scores of anxiety subscale items endorsed by TBI and Comparison groups, 
by gender. 
A 2 x 2 between-group univariate analysis (ANOVA) was carried out to analyse the 
gender and group differences in mean scores between the TBI and comparison groups for 
each anxiety subscale item (8-years post-injury).  The results can be seen in Table 4. 
There was no statistically significant interaction or main effects for scores on items “I 









































































Appendix D).  There was a statistically significant interaction between the group membership 
and gender on the mean score for the item “I get sudden feelings of panic”,  F(1,352) = 4.094, 
p = .044, h2 =.011, with females in the MTBI group scoring significantly higher and males 
scoring significantly lower than those in the comparison group.   There was significant main 
effect of group on the item “I feel restless as if I have to be on the move”,  F(1,352) = 5.132, 
p = .024, h2 =.014, with significantly higher scores on this item from the MTBI group.  There 
was a significant main effect of gender on the items “I get a sort of frightened feeling as if 
something awful is about to happen”, F(1,352) = 8.765, p = .003, h2 =.024, “I can sit at ease 
and feel relaxed”, F(1,352) = 5.796, p = .017, h2 =.016, “I get a sort of frightened feeling like 
butterflies in the stomach”, F(1,352) = .263, p = .002, h2 =.028, and “I get sudden feelings of 
panic”, F(1,352) = 13.545, p = .000, h2 =.037, with significantly higher scores on these items 
























































.72 .685 .78 .692 .73 .566 .81 .661    
Frightened 
feeling 
.50 .683 .86 .871 .72 .877 .90 .910   Ö 
Worrying 
thoughts 
.75 .790 .94 .918 .97 .948 1.06 .867    
Sit at 
ease/relax 
.75 .569 .93 .805 .62 .648 .80 .770   Ö 
Butterflies .38 .610 .56 .645 .47 .594 .72 .670   Ö 
Feel restless .89 .842 .96 .904 .73 .679 .74 .769   Ö  
Sudden panic .36 .667 .81 .861 .56 .756 .69 .679  Ö  Ö 
 
Summary.  
For depression, the MTBI group had higher scores than the comparison group overall 
and, within both groups, females scored higher than males.  However, there were no 
statistically significant differences in mean HADS scores between groups or genders for 
depression at the 8-year point post-MTBI.  
In contrast, for anxiety scores, the comparison group had higher scores than the TBI 
group overall and, within both groups,  females scored higher than males.  There were no 
statistically significant differences in mean HADS scores between groups for anxiety at the 8 
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year point post-MTBI.  Female anxiety scores from both groups were significantly higher 
than males. 
 In terms of HADS scores which exceeded the clinical cut-off score for 
depression, more TBI participants scored within the clinical range than those from the 
comparison group (6% compared to 2.9%).  Over 73% of those participants exceeding the 
clinical cut-off score were female.  There was no association between group membership and 
exceeding clinical cut-off score and there was no association between gender and exceeding 
clinical cut-off score for depression.   
For anxiety, the proportion of participants exceeding clinical cut-off was similar for 
both the TBI and comparison groups (5.4% compared to 5.3% respectively).  Of those within 
the clinical range for anxiety, over 68% were female.  There was no association between 
group membership and exceeding clinical cut-off score for anxiety and there was no 
association between gender and exceeding clinical cut-off score for anxiety.   
With regard to depression symptom items, there were no significant gender 
differences in item scores between groups.  Mean scores for the items “I still enjoy the things 
I used to enjoy”, “I look forward with enjoyment to things” and “I can enjoy a good book or 
radio or TV program” were significantly higher in the MTBI group but with no differences 
between genders.  For both groups females scored significantly higher than men on the item 
“I feel as if I am slowed down”. 
 For anxiety items, there was a significant gender difference between groups 
for the score for the item “I get sudden feelings of panic” in that females in the MTBI group 
had significantly higher mean scores than males.  However, the effect size, or proportion of 
variance attributed to group and gender was small.  For the item “ I feel restless as if I have to 
be on the move”, the MTBI group scored significantly higher than the comparison group.  
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For the items “ I get a sort of frightened feeling as if something awful is about to happen”; “I 
can sit at ease and feel relaxed”, “ I get a sort of frightened feeling like ‘butterflies’ in the 
stomach” and “I get sudden feelings of panic”, females scored significantly higher than 




This thesis investigated the gender differences in depression and anxiety over time 
following a mild traumatic brain injury, using the Hospital Anxiety and Depression Scale.  
This overall aim was two-fold: the first was to identify gender differences in the recovery 
trajectory of depression and anxiety over 1-month, 12-month and 8-year timepoints post-
injury.  The second was to investigate the gender differences in depression and anxiety scores 
between a group of MTBI subjects (8-years post-injury) and a group of participants who were 
TBI-free, by comparing Hospital Anxiety and Depression Scale (HADS) scores and self-
reported symptoms. 
Among the MTBI participants in the current study, female depression and anxiety 
scores were significantly higher than males across the assessment periods.  For both males 
and females, depression scores significantly increased between 12-months and 8-years and, 
conversely, anxiety scores decreased significantly between 1-month and 12-months and 
between 1-month and 8-years post-injury.  For both depression and anxiety the mean scores 
at each time point fell within the normal (non-clinical) range, and the average recovery 
trajectory did not differ between males and females over time.  Within the MTBI group the 
number of people scoring within the clinical range for depression followed the same pattern 
as the mean scores.  For depression, males and females were equally as likely to obtain 
clinical range scores across all assessment timepoints.  Similarly, for anxiety, at the 1-month 
and 8-year follow-up males and females were equally as likely to obtain a clinical range 
score; however, at 12-months post-injury, females were more likely than males to experience 
anxiety at the clinical severity level.  However, this was not apparent in the total mean score 
analysis.  Most people who met clinical levels for depression or anxiety only did so on one 
occasion across the whole assessment period.   
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The group comparisons at 8-years post-injury between the MTBI and TBI-free groups 
found no significant differences in average scores for depression and anxiety and no gender 
differences between groups.  In addition, there was no significant relationship found between 
group or gender and obtaining a clinical-range score which means that females in either 
group were no more likely than males to report clinical severity symptoms for depression or 
anxiety.  However, females overall in both groups had significantly higher mean anxiety 
scores than males at 8-year follow-up though these average scores were not within the 
clinical range.  
When evaluating individual symptom items there were no gender differences in 
depression item scores between groups.  The MTBI group scored significantly higher scores 
than the TBI-free group on the depression items: “I still enjoy the things I used to enjoy”, “I 
look forward with enjoyment to things“ and I can enjoy a good book or radio or TV 
program”.  In both groups, females had significantly higher scores on the item “I feel as if I 
am slowed down” than males. 
With regard to anxiety items, there was a significant, but small, difference between 
how females and males in the MTBI group scored for the item “I get sudden feelings of 
panic” compared to the TBI-free group.  Females in the MTBI group scored significantly 
higher and males scored significantly lower.  Overall in both groups, females scored 
significantly higher than males on this item but the difference in scores between genders was 
particularly marked in the MTBI group.  The MTBI group had significantly higher scores on 
the anxiety item “I feel restless as if I have to be on the move” than the TBI-free group.  In 
both groups, females also scored significantly higher than males on the items “I get a sort of 
frightened feeling as if something awful is about to happen, “I can sit at ease and feel 
relaxed”, I get a sort of frightened feeling like butterflies in my stomach”.   
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Gender Differences in Depression and Anxiety over Time – MTBI group 
The results of the current study found no difference between males and females in the 
course of depression and anxiety up to 8-years’ post-injury although females experienced 
increased depression and anxiety compared to males across the three follow-up assessment 
periods.   This is consistent with previous research that has found that, overall, females have 
higher levels of post-MTBI depression and anxiety than males (Barker-Collo et. al., 2018; 
Farace & Alves, 2000; Merritt, Padgett & Jack, 2019; Scholten et al., 2016) and that female 
gender is an independent predictor of depression at 10 weeks and 1 year following a TBI 
(Singh et al., 2019).  The pattern observed in other shorter follow-up studies remains 
consistent in the current study up to eight years after injury: in Barker-Collo et al., (2018), for 
example, females produced significantly higher scores for both anxiety and depression at 
baseline and 6-months post-MTBI and for anxiety at 12 and 48-months post-injury.  These 
reports are also consistent with the finding that in the general population females have a 
higher prevalence of both depression and anxiety than males (National Alliance on Mental 
Illness, 2016; Faravelli et al., 2013).   
In terms of whether more females or males scored in the clinical range for depression 
and anxiety across timepoints, the current study found that for depression males and females 
were equally as likely to report more severe symptoms across the timepoints.  For anxiety, 
after 1-month and 8-years females with MTBI were equally as likely as males to obtain 
clinical range scores but at 12-months’ post-injury females were more likely than males to 
score in the clinical range. This could be due to females having increased expectations of 
recovery or greater demands after one year has passed, or due to under-reporting by males as 
suggested by Miyashita et al., (2016). This result indicates that females may experience 
anxiety difficulties in greater severity than males at 12-months post-injury which could 
signify a peak for women at this point.  Although this was not evident in the total scores 
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analysis it was also reflected in the proportion of women who reported increased levels of 
anxiety at 12-months post-injury. 
Recovery Trajectory – Depression. 
Results show that, overall, for both males and females, average depression scores in 
the MTBI group remained low but significantly increased from 12-months to 8-years, as did 
the proportion of people who scored within the clinical range for depression.  This could 
indicate that depression may worsen in the longer-term following a MTBI, particularly after 
12-months post-injury.  The current study findings do not concur with the downward 
trajectory found by Barker-Collo et al., (2015 and 2018) that showed depression scores 
significantly decreased from baseline to 48 months post-injury.  However, their 48-month 
outcome study (2018) showed that the proportion of those with depression scores in the 
clinical range (HADS >7) increased from 2.2% at 12-months post-injury to 7.7% at 48-
months post-injury.  This could suggest a longer-term trajectory of increased depression for 
some people following MTBI in concurrence with Konrad et al., (2011) who found that after 
6-years post-MTBI, emotional sequelae continued to be experienced by participants.  My 
findings show that the proportion of the MTBI group with depression scores in the clinical 
range (>11) at 8-years was 6.1% which is comparable with the 12-month population 
prevalence of depression of 7.9% (Scott et al., 2010), suggesting that there is no higher risk of 
depression for those with MTBI in the long-term.  This is in accordance with my findings that 
at 8-years post-MTBI there were no differences in depression levels between the MTBI and 
comparison (TBI-free) group.  It is also consistent with other research findings that 
depressive symptom reporting did not differ between MTBI and control groups at 12-months 
post-injury (Waljas et. al., 2015) and that at 12-months post-injury, levels of depression were 
comparable with the general population (Theadom et. al., 2016). 
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Overall, although depression may be quite common in patients with MTBI, 
particularly in women, and may seem to increase over time, it is not necessarily more 
common than in people in the general population, contrary to the view held by Kessler et al., 
(2003), Konrad et al., (2011) and other prevalence studies (e.g., Scholten et al., 2016).  
Most people who scored in the clinical range for depression were single cases over the 
whole assessment period and no participants obtained a clinical range score at every 
assessment point.  This suggests that the intensity of these symptoms fluctuate, rather than 
persist, over time and could therefore be due to other non-TBI related biopsychosocial 
factors, such as heritability and other environmental risk factors, (Sullivan et al., 2000; Singh 
et al., 2019).  This fluctuation is consistent with studies showing that many of those with 
initial depression at 10 weeks had it resolved by 12-months and some people with depression 
at 12-months had not shown depression symptoms at 10 weeks (Barker-Collo et al., 2015; 
Singh et al., 2019). 
Recovery Trajectory – Anxiety. 
My findings showed that most people obtained scores in the clinical range for anxiety 
at 1-month (3.85% male, 6.73% female) before it decreased at 1-year (0.83% male, 6.61% 
female) and decreased again at 8-years (1.37% male, 4.11% female), consistent with the 
decline in total mean scores and with findings by Singh et. al., (2019) that the majority of 
(HADS >8) clinical range scores were at 10 weeks post-injury and reduced by 1-year.  My 
findings continue the downward trajectory found by Barker-Collo et. al., (2018) that showed 
a reduction in anxiety from baseline to 48 months post-injury.  However their study also 
showed that the proportion of those with anxiety scores in the clinical range (>7) fluctuated 
across the timepoints, decreasing from 29.5% to 3.7% baseline to 6 months and then 
increasing to 25.5% at 12-months before decreasing to 13.6% at 48-months post-injury.  This 
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could suggest that whilst the number of those experiencing clinical range levels of anxiety 
post-MTBI reduces over time, the direction is not linear due to a range of other influencing 
factors not related to TBI. 
In contrast to depression, current research could indicate that anxiety may be at its 
worst in the acute phase after MTBI. However, my study’s prevalence rate of 10.6% at one 
month was lower than the general 12-month prevalence rate of anxiety in New Zealand of 
14.8%.  The percentage of MTBI participants with scores in the clinical range at the 8-year 
follow-up was almost the same as the comparison group (5.4% vs. 5.3%) and the MTBI 8-
year follow-up scores were not significantly different to the comparison group in my study.  
This suggests that although anxiety is experienced by people after a MTBI, it appears to 
decrease in the longer term, and is no more common than in the general population (Theadom 
et al., 2016).  Most people who scored within the clinical range for anxiety did so on only one 
occasion over the whole assessment period and no person reported a clinical range score at 
every assessment point.  As with depression, this suggests that the intensity of these 
symptoms fluctuate, rather than persist, over time and could therefore be due to other non-
TBI related biopsychosocial factors (Moldover et al., 2004). 
Gender Differences in Depression and Anxiety between MTBI and 
Comparison Groups 
My findings show that there were no gender differences between the MTBI and TBI-
free groups in average levels of depression and anxiety experienced and that there was no 
elevated risk of experiencing depression or anxiety for those people who were 8-years’ post-
MTBI compared to those who were TBI-free.  This indicates that after 8-years post-MTBI 
any onset of depression or anxiety is not related to the head injury.  Females in both groups 
reported increased anxiety symptoms compared to males overall, which again may support 
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current evidence that there is a higher female prevalence of anxiety in the general population 
(Faravelli et al., 2013). 
In terms of individual symptom reporting, the finding that people in the MTBI group 
reported greater severity symptoms for the depression items “I still enjoy the things I used to 
enjoy, “I look forward with enjoyment to things” and “I can enjoy a good book/radio/TV 
programme” suggests a statistically significant higher level of anhedonia within the TBI 
group, which is a major flagship symptom of depression. Indeed, research on the association 
between HADS items and 12-month post-injury diagnosis of anxiety and depression, found 
that the item “I still enjoy the things I used to enjoy” was highly associated with a 12-month 
post-injury psychiatric SCID diagnosis (Structured Clinical Interview for DSM-IV) 
(McKenzie, Downing and Ponsford, 2018).  This is of clinical relevance as it emphasises the 
importance of looking at individual symptom scores of measures, in particular the HADS, 
and not solely at total subscale scores.  The MBTI group scores for the item “I feel restless as 
if I have to be on the move” were significantly higher than the comparison group and this 
could indicate latent post-concussional syndrome which commonly includes irritability and 
attention problems and which can overlap with depression and anxiety symptoms (Waljas et 
al., 2015).   
Although this current study did not find significant gender differences in levels of 
depression and anxiety experienced between those in the MTBI group and those in the 
comparison group, there was some evidence of gender differences in symptom 
reporting/endorsement overall. 
For the item “I feel as if I am slowed down” the scores from female participants in 
both groups were statistically significantly higher than males indicating that females may 
experience higher levels of this symptom than males in the general population.  This is 
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consistent with Iverson and Stearne, (2006) who found that, prior to concussion, their female 
participants reported higher post-concussive symptoms overall and that they were more likely 
to report mild emotional symptoms including “feeling slowed down” than were males.  It is 
possible therefore that females are more likely to endorse greater depression symptoms than 
males even prior to a head injury which again supports the evidence that there is a higher 
population prevalence of depression in females.  It is also worth noting that ‘feeling slowed 
down’ is also a commonly reported TBI post-concussive syndrome sequelae (Barker et al., 
2015). 
The finding that females in the MTBI group experienced the symptom “I get sudden 
feelings of panic” more greatly than females in the comparison group could indicate that, 
after 8-years post-injury, females are more vulnerable to increased anxious symptoms.  This 
is in line with research suggesting that injury to the brain can affect stress hormones, 
particularly in women (Mollayeva et al., 2018; Faravelli et al., 2013).  However, the effect 
size was small for the group difference.  Females across both groups scored significantly 
higher than males for this symptom but this gender difference was significantly greater in the 
MTBI group. 
In terms of gender overall, across both groups, females also scored significantly 
higher on the items “I get a sort of frightened feeling as if something awful is about to 
happen, “I can sit at ease and feel relaxed” and “I get a sort of frightened feeling like 
'butterflies' in the stomach.  These symptom analysis results could reflect gender differences 
in how symptoms are reported by females as compared to males.  These items can be 
compared to those areas suffered more greatly by females in the general population as 
reported in the study by Angst et al., (2007), including work impairment (which may relate to 
feeling slowed down), social impairment and distress and feeling fearful with muscle tension 
which may relate to items endorsing a ‘frightened feeling’, ‘sudden panic’ and ‘butterflies’.   
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Strengths & Limitations 
This study investigated long-term outcomes of a population-based sample of adults in 
the community who had sustained a mild traumatic brain injury and this reduced potential 
severity bias which may have occurred from studies using samples from hospital admissions 
only.  The MTBI sample was large and included a broad range of participants for more 
comprehensive results.  This research is a unique contribution to current research in that it 
extends the timepoint over which previous studies have measured MTBI outcomes in the 
longer-term, to 8-years and specifically relates to gender.  It also allows for post-injury 
comparisons to be made to the general population as well as appraising the recovery 
trajectory over time.  Given the heterogenous nature of post-injury depression and anxiety 
outcomes over time, longitudinal studies are important to inform clinical practice of specific 
risk and protective factors salient to depression and anxiety following MTBI, so that people 
affected can access timely interventions as needed.  A limitation of this study was the 
variability of the sample over time in that the follow-up assessments did not include all of the 
cases identified in the original study and therefore the current sample may have been biased. 
Use of a single measure (HADS) is a strength as it enables direct comparisons to be 
made over time.  However, it is also a weakness, and additional measures, for example the 
structured clinical interview for DSM (SCID),  may have made assessment of depression and 
anxiety more accurate rather than relying on self-report which has its limitations (Uher et al., 
2012).  Self-reported measurements may be unreliable in a TBI population because of the 
overlap between mood symptoms and PCS (for example irritability, fatigue, memory deficits, 
low self-awareness, attention problems) and evidence that TBI patients tend to underestimate 
their problems (Cnossen et al., 2017).  The SCID may be advantageous as it distinguishes 
between psychopathology symptoms and TBI symptoms and structured interviews are less 
influenced by TBI related problems such as memory deficits.  There may also be cultural, as 
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well as gender-based, variances in how participants respond to the HADS questions in terms 
of interpretation of meaning or presence of any stigma regarding mental illness symptoms, 
and so a broader range of measures would mitigate this risk, as well as identify additional 
individual environment risk factors for depression and anxiety.   
In terms of identifying the clinical range at which depression and anxiety is 
diagnosed, this can vary greatly based on what measurement criteria are used (e.g., HADS, 
DSM, ICD-10) and the clinical range cut-off that is used.  As the current study used a HADS 
definition (>11), it is more useful to make comparisons with other studies using this measure 
which may then limit the scope of evaluation.  
This study examined group rather than individual level outcomes which excludes 
many other variables contributing to the multiple trajectories of depression and anxiety over 
time, such as pre-morbidity, co-morbidity, recurrent TBI, and biopsychosocial factors that 
were not controlled for in this study and so the level of influence these factors have had on 
the degree of depression and anxiety experienced over 8-years by the study’s MTBI 
participant group is unknown. 
Recommendations for future research 
Based on the results of my study, there are several recommendations for future 
research.  As my findings show the trajectory of depression and anxiety post-MTBI up to 8-
years after injury, further follow-up studies beyond this period could determine the longer-
term course of depression and anxiety after MTBI and whether depression does continue to 
increase further compared to levels within the general population.   
Some of the limitations outlined in this study may be minimised by incorporating 
additional measures of depression and anxiety to gain a more comprehensive account of the 
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symptoms experienced by the study participants.  Additionally, to control for other 
demographic/biopsychosocial factors that might influence the reporting of depression and 
anxiety apart from the MTBI.  A measure such as the Life Events Checklist may assist with 
controlling for these variables over the long-term analysis.  Similarly, as MTBI may be a 
separate diagnosis to moderate-severe TBI with different risk factors, outcome trajectories, 
and gender effects with regard to the expression of depression and anxiety, future research 
could identify how these factors can, and not in association with head injury, account for 
persistent post-concussive symptoms (Suhr & Gunstad, 2002).   Additionally, as we know 
that females report higher levels of depression and anxiety than males in the general 
population, further research on how the expression of these symptoms manifest in, and are 
reported by, men may help to understand these differences and target assessment and 
treatments effectively and gender-sensitively, particularly as males have an increased risk of 
TBI compared to females (Saunders et. al., 2009).  
 A high co-morbidity rate of depression and anxiety has been found in the 
MTBI population, though not in my study sample, and further analysis to determine if those 
with a co-morbid diagnosis are at greater risk of poor outcomes or persistent symptoms 
following MTBI would also contribute to the identification and prioritisation of effective 
treatment interventions.  Given that depression and anxiety appear to have a different 
prognostic and recovery course trajectory in this study, and as suggested by Penninx et. al., 
(2011), it could be clinically beneficial to assess and treat these two disorders differently as 
part of the assessment and treatment process following MTBI. 
In addition, as we know that PCS symptoms can overlap with depression  (Waljas et 
al., 2015), in order to predict long-term depression and anxiety symptoms from acute PCS 
assessment, future research could include identifying a specific measure or heuristic for 
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identifying depression and anxiety in the acute phase of MTBI that may detect long-term 
outcomes in males and females.   
Conclusion 
Understanding the relationship between gender and depression and anxiety symptoms 
following MTBI is important in planning the most effective treatment and rehabilitation post-
injury.  This is the first study to assess gender differences in the levels of depression and 
anxiety 8-years after sustaining a MTBI and as compared to a general population comparison 
group.  Overall, results suggest that males and females with MTBI have the same overall and 
fluctuating course of recovery in relation to depression and anxiety symptoms over the 8-
years following injury, but that females consistently report higher levels of depression and 
anxiety than males over this time.  Whilst this is consistent with the female prevalence of 
depression and anxiety in the general population, these symptoms can impede recovery and 
quality of life after a MTBI.     
In comparisons between the MTBI and TBI-free groups, results showed that there 
were no gender differences in depression or anxiety between these groups and females in 
both groups reported increased anxiety compared to men, which again reflects the trend in the 
general population.  Individual symptom differences were found between groups and 
genders: both males and females with MTBI showed increased anhedonia and restlessness, 
and females with head injury experienced more elevated panic symptoms than females with 
no head injury.  Females in general experienced more severe nervousness and feeling slowed 
down symptoms than males which points to specific characteristics of the expression of 
depression and anxiety in females. 
Whilst longitudinal studies are extremely valuable to track recovery over time in a 
participant group, my study demonstrates that a control group comparison gives meaning to 
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this information across the general population and that individual item analysis can provide a 
greater understanding of gender and group differences in self-reported symptoms not 
revealed by total score analysis.  The fact that there is a significant difference between males 
and females in the general population with regard to depression and anxiety may reflect 
actual gender differences in how these problems manifest and/or it could reflect the different 
attitudes towards reporting symptoms which can bias data collected from measures like the 
HADS.   From a clinical perspective being cognisant of this, and the fact that males may 
under-report depression and anxiety symptoms, is important in the differentiation of effective 
assessment and treatment in both males and females.  Other clinical implications of this study 
suggest a focus on the longer-term impacts of MTBI and that even if a patient does not 
present with depression or anxiety symptoms at the acute phase following injury, it may not 
exclude onset later on.  Providing awareness of this possibility to the patient as well as 
regular assessment of individual symptoms over time may therefore be needed, particularly 
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